$SMMR U C, Inc., SMMR, Appoints New Board Member and CEO
Press Release | 02/21/2022
LONGWOOD, Fla., Feb. 21, 2022 (GLOBE NEWSWIRE) -- U C, Inc., formerly named Symmetry Technologies, Inc. (OTC: SMMR), (the "Company"), announced today that, effective Feb. 14, 2022, it has appointed David Reckles as a new member to its Board of Directors, its Chief Executive Officer ("CEO") and corporate Treasurer.

During the past three years, Mr. Reckles has been active in the private label hemp and CBD manufacturing industries. Previously, he spent 20+ years in corporate America as a Chief Technologist and CTO for companies such as American Airlines, AT Kearney, BP, Dell, Dow, EDS, Gap, Pfizer, and United Airlines. He additionally served HP/EDS as an Enterprise Architect and Chief Technologist for many client and company initiatives, with particular emphasis on Information Technology Innovation, automation, configuration management, and mobile technologies.

Donna Rayburn, who has been the CEO and Sole Director of the Company, will assume the role of Chairperson of the Board of Directors of the Company, but will no longer be an officer of the Company.

Separately, the Company is also announcing that it has filed a request with the Financial Regulatory Authority ("FINRA") for an immediate name change and change in trading symbol. Once approved, the Company will issue an announcement on the date of change implementations.

About U C, Inc. U C, Inc. is a publicly-traded company on the OTC Market, under the symbol "SMMR". It was founded as a Nevada corporation in 2001 under the name "Symmetry Technologies, Inc." Today, the Company is a holding company pursuing a business plan of the acquisition over time of majority interest in several companies, each having revenues in excess of $1,000,000, positive EBITDA (earnings before interest, taxes, depreciation and amortization) and positive cash flow.

Safe Harbor: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:

U C, Inc.
Phone: 954-715-5020

$SMMR U C, Inc., SMMR, Appoints New Board Member and CEO
Press Release | 02/21/2022
LONGWOOD, Fla., Feb. 21, 2022 (GLOBE NEWSWIRE) -- U C, Inc., formerly named Symmetry Technologies, Inc. (OTC: SMMR), (the "Company"), announced today that, effective Feb. 14, 2022, it has appointed David Reckles as a new member to its Board of Directors, its Chief Executive Officer ("CEO") and corporate Treasurer.

During the past three years, Mr. Reckles has been active in the private label hemp and CBD manufacturing industries. Previously, he spent 20+ years in corporate America as a Chief Technologist and CTO for companies such as American Airlines, AT Kearney, BP, Dell, Dow, EDS, Gap, Pfizer, and United Airlines. He additionally served HP/EDS as an Enterprise Architect and Chief Technologist for many client and company initiatives, with particular emphasis on Information Technology Innovation, automation, configuration management, and mobile technologies.

Donna Rayburn, who has been the CEO and Sole Director of the Company, will assume the role of Chairperson of the Board of Directors of the Company, but will no longer be an officer of the Company.

Separately, the Company is also announcing that it has filed a request with the Financial Regulatory Authority ("FINRA") for an immediate name change and change in trading symbol. Once approved, the Company will issue an announcement on the date of change implementations.

About U C, Inc. U C, Inc. is a publicly-traded company on the OTC Market, under the symbol "SMMR". It was founded as a Nevada corporation in 2001 under the name "Symmetry Technologies, Inc." Today, the Company is a holding company pursuing a business plan of the acquisition over time of majority interest in several companies, each having revenues in excess of $1,000,000, positive EBITDA (earnings before interest, taxes, depreciation and amortization) and positive cash flow.

Safe Harbor: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:

U C, Inc.
Phone: 954-715-5020

$YUKA Yuka Group Inc. Continues to Expand Reach Through Sales of Medical-Grade Devices with Home Shopping Network: ShopLC
Press Release | 02/21/2022
MIAMI, FL / ACCESSWIRE / February 21, 2022 / Yuka E-Commerce (OTC Pink:YUKA) ("YUKA") is a wholly-owned subsidiary of Yuka Group, Inc. ("the Company") which is entering Mid-Q1 with some exciting new growth initiatives.

Shop LC, formerly known as Liquidation Channel, is an American cable television network based in Austin, Texas, which mainly specializes in the sales of jewelry, beauty, fashion, home decor and lifestyle products. The current network's reach is approximately 77 million households in the United States alone. Although Shop LC is mainly a cable channel, it has 39 over-the-air affiliates in mid-to-major markets through digital sub-channels.

"Our ability to provide cutting-edge technology products and high-end brands keeps us at the forefront of our Buyer's demands to supply them with goods." said Meir Avitan, President of Yuka Group Inc. "With less than 2 months into Q1 alone the network surpassed over $150K in sales from goods supplied by us, and we anticipate to double this number before the end of this quarter," He added. "We carry an impressive portfolio of over 150+ world-renowned brands with Medical Grade At-Home Beauty Tools pioneering our growth."

About Yuka E-Commerce

Yuka is an e-commerce company dedicated to providing strategic sales channels for brands looking to enter or expand in the global e-commerce market. YUKA provides a full spectrum of brand building and sales-and-marketing services to expand a client's brand reach. Services offered include not only comprehensive sales and marketing services, but also operational sales and fulfillment logistics, and product and brand photography.

For more information, visit our website at www.yukaecom.com

About Yuka Group, Inc.

Yuka is a company with a notable focus on nurturing companies that demonstrate a positive upside while striving to bring new technologies and unique products to their respective markets.

For more information, visit our website at www.Yukaecom.com

Safe Harbor Statement:

This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may," or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- activities of competitors and the presence of new or additional competition and conditions of equity markets.

Find out more about the company here:

$YUKA Yuka Group Inc. Continues to Expand Reach Through Sales of Medical-Grade Devices with Home Shopping Network: ShopLC
Press Release | 02/21/2022
MIAMI, FL / ACCESSWIRE / February 21, 2022 / Yuka E-Commerce (OTC Pink:YUKA) ("YUKA") is a wholly-owned subsidiary of Yuka Group, Inc. ("the Company") which is entering Mid-Q1 with some exciting new growth initiatives.

Shop LC, formerly known as Liquidation Channel, is an American cable television network based in Austin, Texas, which mainly specializes in the sales of jewelry, beauty, fashion, home decor and lifestyle products. The current network's reach is approximately 77 million households in the United States alone. Although Shop LC is mainly a cable channel, it has 39 over-the-air affiliates in mid-to-major markets through digital sub-channels.

"Our ability to provide cutting-edge technology products and high-end brands keeps us at the forefront of our Buyer's demands to supply them with goods." said Meir Avitan, President of Yuka Group Inc. "With less than 2 months into Q1 alone the network surpassed over $150K in sales from goods supplied by us, and we anticipate to double this number before the end of this quarter," He added. "We carry an impressive portfolio of over 150+ world-renowned brands with Medical Grade At-Home Beauty Tools pioneering our growth."

About Yuka E-Commerce

Yuka is an e-commerce company dedicated to providing strategic sales channels for brands looking to enter or expand in the global e-commerce market. YUKA provides a full spectrum of brand building and sales-and-marketing services to expand a client's brand reach. Services offered include not only comprehensive sales and marketing services, but also operational sales and fulfillment logistics, and product and brand photography.

For more information, visit our website at www.yukaecom.com

About Yuka Group, Inc.

Yuka is a company with a notable focus on nurturing companies that demonstrate a positive upside while striving to bring new technologies and unique products to their respective markets.

For more information, visit our website at www.Yukaecom.com

Safe Harbor Statement:

This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may," or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- activities of competitors and the presence of new or additional competition and conditions of equity markets.

Find out more about the company here:

$ENZC Enzolytics Announces Its New Technology For Entry Into The In-Vitro Diagnostics Market
Press Release | 02/21/2022
COLLEGE STATION, TX / ACCESSWIRE / February 21, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) announces its plans for entry into the diagnostics market. Enzolytics has filed a comprehensive U.S. and foreign Patent Cooperation Treaty (PCT) Patent Application covering its invention of a novel, innovative technology for improved diagnostics. The PCT Application covers the Company's identification of highly conserved antigens and epitopes of SARS-CoV-2 that can be used in vaccines and to produce bindings proteins (e.g., antibodies) for treating, preventing, or reducing the risks of infections caused by ß-coronaviruses such as SARS-CoV-2. The patent also covers the discovery of using these identified antigens and epitopes as targets for detecting and diagnosing SARS-CoV-2 infection.

The Company's Artificial Intelligence platform has been used to build 3D Models of the conserved targets. The analysis of the SARS-CoV-2 spike protein revealed that all epitopes identified by the Company are linear on the spike proteins, accessible by antibodies, neutralizable, and unaffected by mutations.

The Company's finding provides the basis for addressing the challenge posed by the fast evolution of SARS-CoV-2 variants having mutations in their genomic and protein sequences, which have precluded the development of effective methods for accurately detecting infection. The effect of mutations on a test's performance may be influenced by several factors, including the sequence of the variant (including the number, identity, and location of mutations), the design of the test, and the prevalence of the variant in the population. For example, tests with single targets are more likely to fail to detect new variants. On the other hand, tests with multiple targets (e.g., a PCR test designed to detect more than one section of the SARS-CoV-2 genome or an antigen test intended to detect more than one region of the spike protein) can more accurately detect new variants. For example, a molecular test able to detect other variants is expected to fail to detect the SARS-CoV-2 Omicron variant (B.1.1.529) due to a nine-nucleotide deletion in the N-gene, spanning positions 28370-28362, while a two-target antigen test able to detect other variants is expected to fail to detect the Omicron variant due to deletions at amino acid positions 69-70 and mutations at nucleotide positions 23599.

Enzolytics is developing tests that diagnose SARS-CoV-2 based on the presence of the conserved sites that remain unaffected by mutations. Using its Artificial Intelligence technology, all the conserved sites identified by the Company have remained present in all of the variants of concern and variants of interest.

Enzolytics is currently working with diagnostic companies with track records for taking this technology and the tests produced under it through regulatory approval, leading to patient use.

The global in-vitro diagnostics market was valued at approximately U.S. $68.41 Billion in 2020. The market value is expected to increase to U.S. $91.25 Billion in revenue in 2026, with a CAGR of 4. 90% over the forecast period.

The COVID-19 pandemic turned attention to in-vitro diagnostics. As a result, there is an increasing demand for IVD kits and reagents for the rapid and accurate diagnosis of SARS-CoV-2 virus infection among the global population. The outbreak of COVID-19 is expected to positively impact the market studied, as in-vitro diagnostics involves the testing of various biological samples. This is expected to aid the diagnosis of infectious diseases, such as COVID-19. Therefore, testing remains a crucial step in controlling the COVID-19 pandemic. As a result, there is an increased push for faster, reliable, and accurate diagnosis of SARS-CoV-2. The Company's new technology addresses this need.

This new technology is supplemental and additive to the Company's multiple technology platforms, which include:

The Company's immune modulator IPF Immune™ coming to the U.S. market in March.

The Company's development of ITV-1 therapeutic for treating HIV.

The Company's production of anti- HIV Monoclonal Antibodies.

The Company's production of anti-SARS CoV-2 Monoclonal Antibodies.

The Company's planned production of Monoclonal Antibodies addressing animal viruses such as the Equine Infectious Anemia Virus, Feline Leukemia Virus, Feline Immunodeficiency Virus, Equine Herpesvirus (EHV), Koala Retrovirus (KoRV), and the Elephant Endotheliotropic Herpesvirus (EEHV).

The Company's Artificial Intelligence (A.I.) Platform including:

A.I. Analysis to identify immutable sites. 3D Modelling of the epitopes to establish linearity, neutralizing potential and accessibility to antibodies.

A.I. to assess the effects of nutrition, genetics, and microbiome on diseases to:

Build prediction models for infectious diseases (preferably COVID), mental health disorders, and chronic medical diseases.
Identify biomarkers for infectious diseases and chronic medical diseases.
Identify novel targets and clear intervention strategies for infectious diseases and chronic medical diseases.
A.I. Platform for genomic surveillance, monitoring of viral epidemiology.

About Enzolytics, Inc.

Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins and monoclonal antibodies for the treatment of debilitating infectious diseases. The Company is advancing multiple therapeutics targeting numerous infectious diseases. One patented and clinically tested compound, ITV-1 (Immune Therapeutic Vaccine-1), is a suspension of Inactivated Pepsin Fraction (IPF), covered by U.S. Patent Nos. 8,066,982 and 7,479,538. Studies have shown it to be effective in treating HIV/AIDS. ITV-1 has also been shown to modulate the immune system.

The Company is also implementing its proprietary technology to produce fully human monoclonal antibodies (mAbs) against infectious diseases, including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. Its proprietary methodology, covered in its pending U.S. Patent Application for producing fully human monoclonal antibodies, is currently employed to produce monoclonal antibody therapeutics for numerous infectious diseases, including the CoronaVirus (SARS-CoV-2) and HTLV-1.

Safe Harbor Statement: This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Enzolytics, Inc. from time to time in its periodic reports filed with the SEC. ITV-1 is not approved by the U.S. Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world.

While Enzolytics, Inc. believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Enzolytics to establish the efficacy of its therapeutics in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of its therapeutics in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, and the successful outcome of such studies or tests. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate.

Such forward-looking statements are based on current expectations. They involve inherent risks and uncertainties, including factors that could delay, divert or change any of the statements made, and cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. These forward-looking statements are made as of the date of this press release. The Company expressly disclaims any intention or obligation to update the forward-looking statements or update the reasons why actual results could differ from those projected in the forward-looking statements.

I.R. contact:
TEN Associates, LLC
Tom Nelson, CEO
(480) 326-8577

Company Contact:
Enzolytics, Inc.
2000 North Central Expressway
Plano, TX 75074

$ENZC Enzolytics Announces Its New Technology For Entry Into The In-Vitro Diagnostics Market
Press Release | 02/21/2022
COLLEGE STATION, TX / ACCESSWIRE / February 21, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) announces its plans for entry into the diagnostics market. Enzolytics has filed a comprehensive U.S. and foreign Patent Cooperation Treaty (PCT) Patent Application covering its invention of a novel, innovative technology for improved diagnostics. The PCT Application covers the Company's identification of highly conserved antigens and epitopes of SARS-CoV-2 that can be used in vaccines and to produce bindings proteins (e.g., antibodies) for treating, preventing, or reducing the risks of infections caused by ß-coronaviruses such as SARS-CoV-2. The patent also covers the discovery of using these identified antigens and epitopes as targets for detecting and diagnosing SARS-CoV-2 infection.

The Company's Artificial Intelligence platform has been used to build 3D Models of the conserved targets. The analysis of the SARS-CoV-2 spike protein revealed that all epitopes identified by the Company are linear on the spike proteins, accessible by antibodies, neutralizable, and unaffected by mutations.

The Company's finding provides the basis for addressing the challenge posed by the fast evolution of SARS-CoV-2 variants having mutations in their genomic and protein sequences, which have precluded the development of effective methods for accurately detecting infection. The effect of mutations on a test's performance may be influenced by several factors, including the sequence of the variant (including the number, identity, and location of mutations), the design of the test, and the prevalence of the variant in the population. For example, tests with single targets are more likely to fail to detect new variants. On the other hand, tests with multiple targets (e.g., a PCR test designed to detect more than one section of the SARS-CoV-2 genome or an antigen test intended to detect more than one region of the spike protein) can more accurately detect new variants. For example, a molecular test able to detect other variants is expected to fail to detect the SARS-CoV-2 Omicron variant (B.1.1.529) due to a nine-nucleotide deletion in the N-gene, spanning positions 28370-28362, while a two-target antigen test able to detect other variants is expected to fail to detect the Omicron variant due to deletions at amino acid positions 69-70 and mutations at nucleotide positions 23599.

Enzolytics is developing tests that diagnose SARS-CoV-2 based on the presence of the conserved sites that remain unaffected by mutations. Using its Artificial Intelligence technology, all the conserved sites identified by the Company have remained present in all of the variants of concern and variants of interest.

Enzolytics is currently working with diagnostic companies with track records for taking this technology and the tests produced under it through regulatory approval, leading to patient use.

The global in-vitro diagnostics market was valued at approximately U.S. $68.41 Billion in 2020. The market value is expected to increase to U.S. $91.25 Billion in revenue in 2026, with a CAGR of 4. 90% over the forecast period.

The COVID-19 pandemic turned attention to in-vitro diagnostics. As a result, there is an increasing demand for IVD kits and reagents for the rapid and accurate diagnosis of SARS-CoV-2 virus infection among the global population. The outbreak of COVID-19 is expected to positively impact the market studied, as in-vitro diagnostics involves the testing of various biological samples. This is expected to aid the diagnosis of infectious diseases, such as COVID-19. Therefore, testing remains a crucial step in controlling the COVID-19 pandemic. As a result, there is an increased push for faster, reliable, and accurate diagnosis of SARS-CoV-2. The Company's new technology addresses this need.

This new technology is supplemental and additive to the Company's multiple technology platforms, which include:

The Company's immune modulator IPF Immune™ coming to the U.S. market in March.

The Company's development of ITV-1 therapeutic for treating HIV.

The Company's production of anti- HIV Monoclonal Antibodies.

The Company's production of anti-SARS CoV-2 Monoclonal Antibodies.

The Company's planned production of Monoclonal Antibodies addressing animal viruses such as the Equine Infectious Anemia Virus, Feline Leukemia Virus, Feline Immunodeficiency Virus, Equine Herpesvirus (EHV), Koala Retrovirus (KoRV), and the Elephant Endotheliotropic Herpesvirus (EEHV).

The Company's Artificial Intelligence (A.I.) Platform including:

A.I. Analysis to identify immutable sites. 3D Modelling of the epitopes to establish linearity, neutralizing potential and accessibility to antibodies.

A.I. to assess the effects of nutrition, genetics, and microbiome on diseases to:

Build prediction models for infectious diseases (preferably COVID), mental health disorders, and chronic medical diseases.
Identify biomarkers for infectious diseases and chronic medical diseases.
Identify novel targets and clear intervention strategies for infectious diseases and chronic medical diseases.
A.I. Platform for genomic surveillance, monitoring of viral epidemiology.

About Enzolytics, Inc.

Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins and monoclonal antibodies for the treatment of debilitating infectious diseases. The Company is advancing multiple therapeutics targeting numerous infectious diseases. One patented and clinically tested compound, ITV-1 (Immune Therapeutic Vaccine-1), is a suspension of Inactivated Pepsin Fraction (IPF), covered by U.S. Patent Nos. 8,066,982 and 7,479,538. Studies have shown it to be effective in treating HIV/AIDS. ITV-1 has also been shown to modulate the immune system.

The Company is also implementing its proprietary technology to produce fully human monoclonal antibodies (mAbs) against infectious diseases, including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. Its proprietary methodology, covered in its pending U.S. Patent Application for producing fully human monoclonal antibodies, is currently employed to produce monoclonal antibody therapeutics for numerous infectious diseases, including the CoronaVirus (SARS-CoV-2) and HTLV-1.

Safe Harbor Statement: This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Enzolytics, Inc. from time to time in its periodic reports filed with the SEC. ITV-1 is not approved by the U.S. Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world.

While Enzolytics, Inc. believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Enzolytics to establish the efficacy of its therapeutics in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of its therapeutics in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, and the successful outcome of such studies or tests. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate.

Such forward-looking statements are based on current expectations. They involve inherent risks and uncertainties, including factors that could delay, divert or change any of the statements made, and cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. These forward-looking statements are made as of the date of this press release. The Company expressly disclaims any intention or obligation to update the forward-looking statements or update the reasons why actual results could differ from those projected in the forward-looking statements.

I.R. contact:
TEN Associates, LLC
Tom Nelson, CEO
(480) 326-8577

Company Contact:
Enzolytics, Inc.
2000 North Central Expressway
Plano, TX 75074

$UMAX UMAX GROUP CORP. – Funny Media Group in Talks with Vyre Network for “HUGE” Comedy Streaming Deal
Press Release | 02/18/2022
LOS ANGELES, CA / ACCESSWIRE / February 18, 2022 / UMAX Group Corp. (OTC PINK:UMAX), a Nevada corporation, has announced that its subsidiary, Funny Media Group, LLC ("FMG"), is in talks with Vyre Network to distribute Season 1 of FMG's comedy specials-more than 200 shows in all.

"This is HUGE for Funny Media Group," said UMAX President and CEO Rondell Fletcher. "Vyre can bring our comedy content to a global audience."

Vyre Network is a global digital distribution multi-platform service that licenses, live streams, and produces a vast catalog of exclusive content for streaming entertainment. Vyre Network's Web Site: https://vyrenetwork.com/

"They are a state-of-the-art platform, and they are a perfect home for Funny Media Group," Fletcher said.

After the acquisition of Funny Media Group in May 2021, UMAX has now fully transitioned into comedy development as the vehicle to achieve a cash-flow positive operation and to provide the best return on shareholder's investment.

Fletcher oversaw the production of 200 comedy specials for Season 1, and Season 2 begins taping in a few weeks. So far, 50 of the 200 shows have hit YouTube, resulting in more than 2 million views.

"We have built a pipeline of comedy specials that is attracting attention in the industry, and a significant audience on YouTube," Mr. Fletcher says. "Vyre will help us reach millions more."

The shows are filmed in the Comedy Cube, Funny Media Group's state-of-the-art facility in downtown Los Angeles. Shows are released on Mondays, Wednesdays, and Fridays.

Mr. Fletcher has an extensive background in production and media. He has owned his own production studio in Los Angeles for the past 20 years and has produced national shows for CNN, FOX, Food Network and Comedy Central, among others.

The short-term goal for Funny Media Group is to produce content for streaming services such as Netflix and Amazon with the long-term goal of building a large media catalog for acquisition.

Funny Media's comedy show content taped at the Comedy Cube:

https://www.youtube.com/c/FunnyMediaGroup

About Us

UMAX Group Corp. is a Nevada corporation, is a public-quoted Pink Sheet issuer under the ticker symbol "UMAX". UMAX reports as an alternative reporting issuer with OTC Markets Group, Inc. and is current in its mandatory required filings (E.g., "Pink Sheet Current").

Disclaimer Regarding Forward Looking Statements

Certain statements that we make may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning futurestrategic objectives, business prospects, anticipated savings, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions, demand for and pricing of our products, acquisitions and divestitures, anticipated results of litigation and regulatory developments or general economic conditions. In addition, words such as "believes," "expects," "anticipates," "intends," "plans," "estimates," "projects," "forecasts," and future or conditional verbs such as "will," "may," "could," "should," and "would," as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. Forward-looking statements are not guarantees, and they involve risks, uncertainties, and assumptions. Although we make such statements based on assumptions that we believe to be reasonable, there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements. We caution investors not to rely unduly on any forward-lookingstatements.

Company Information:

UMAX Group Corp.

2020 Bay Avenue

Los Angeles, California 90021

Website (FMG): https://funnymediagroup.com/

Website (FMS): https://BroadcastWest.com/

Instagram: https://www.instagram.com/funnymediagroupofficial/?hl=en

YouTube:https://www.youtube.com/c/FunnyMediaGroup

Investor Relations: Jack Zietz

Email: investors@umaxgrpcorp.com

$UMAX UMAX GROUP CORP. – Funny Media Group in Talks with Vyre Network for “HUGE” Comedy Streaming Deal
Press Release | 02/18/2022
LOS ANGELES, CA / ACCESSWIRE / February 18, 2022 / UMAX Group Corp. (OTC PINK:UMAX), a Nevada corporation, has announced that its subsidiary, Funny Media Group, LLC ("FMG"), is in talks with Vyre Network to distribute Season 1 of FMG's comedy specials-more than 200 shows in all.

"This is HUGE for Funny Media Group," said UMAX President and CEO Rondell Fletcher. "Vyre can bring our comedy content to a global audience."

Vyre Network is a global digital distribution multi-platform service that licenses, live streams, and produces a vast catalog of exclusive content for streaming entertainment. Vyre Network's Web Site: https://vyrenetwork.com/

"They are a state-of-the-art platform, and they are a perfect home for Funny Media Group," Fletcher said.

After the acquisition of Funny Media Group in May 2021, UMAX has now fully transitioned into comedy development as the vehicle to achieve a cash-flow positive operation and to provide the best return on shareholder's investment.

Fletcher oversaw the production of 200 comedy specials for Season 1, and Season 2 begins taping in a few weeks. So far, 50 of the 200 shows have hit YouTube, resulting in more than 2 million views.

"We have built a pipeline of comedy specials that is attracting attention in the industry, and a significant audience on YouTube," Mr. Fletcher says. "Vyre will help us reach millions more."

The shows are filmed in the Comedy Cube, Funny Media Group's state-of-the-art facility in downtown Los Angeles. Shows are released on Mondays, Wednesdays, and Fridays.

Mr. Fletcher has an extensive background in production and media. He has owned his own production studio in Los Angeles for the past 20 years and has produced national shows for CNN, FOX, Food Network and Comedy Central, among others.

The short-term goal for Funny Media Group is to produce content for streaming services such as Netflix and Amazon with the long-term goal of building a large media catalog for acquisition.

Funny Media's comedy show content taped at the Comedy Cube:

https://www.youtube.com/c/FunnyMediaGroup

About Us

UMAX Group Corp. is a Nevada corporation, is a public-quoted Pink Sheet issuer under the ticker symbol "UMAX". UMAX reports as an alternative reporting issuer with OTC Markets Group, Inc. and is current in its mandatory required filings (E.g., "Pink Sheet Current").

Disclaimer Regarding Forward Looking Statements

Certain statements that we make may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning futurestrategic objectives, business prospects, anticipated savings, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions, demand for and pricing of our products, acquisitions and divestitures, anticipated results of litigation and regulatory developments or general economic conditions. In addition, words such as "believes," "expects," "anticipates," "intends," "plans," "estimates," "projects," "forecasts," and future or conditional verbs such as "will," "may," "could," "should," and "would," as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. Forward-looking statements are not guarantees, and they involve risks, uncertainties, and assumptions. Although we make such statements based on assumptions that we believe to be reasonable, there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements. We caution investors not to rely unduly on any forward-lookingstatements.

Company Information:

UMAX Group Corp.

2020 Bay Avenue

Los Angeles, California 90021

Website (FMG): https://funnymediagroup.com/

Website (FMS): https://BroadcastWest.com/

Instagram: https://www.instagram.com/funnymediagroupofficial/?hl=en

YouTube:https://www.youtube.com/c/FunnyMediaGroup

Investor Relations: Jack Zietz

Email: investors@umaxgrpcorp.com

$UMAX UMAX GROUP CORP. – Funny Media Group in Talks with Vyre Network for “HUGE” Comedy Streaming Deal
Press Release | 02/18/2022
LOS ANGELES, CA / ACCESSWIRE / February 18, 2022 / UMAX Group Corp. (OTC PINK:UMAX), a Nevada corporation, has announced that its subsidiary, Funny Media Group, LLC ("FMG"), is in talks with Vyre Network to distribute Season 1 of FMG's comedy specials-more than 200 shows in all.

"This is HUGE for Funny Media Group," said UMAX President and CEO Rondell Fletcher. "Vyre can bring our comedy content to a global audience."

Vyre Network is a global digital distribution multi-platform service that licenses, live streams, and produces a vast catalog of exclusive content for streaming entertainment. Vyre Network's Web Site: https://vyrenetwork.com/

"They are a state-of-the-art platform, and they are a perfect home for Funny Media Group," Fletcher said.

After the acquisition of Funny Media Group in May 2021, UMAX has now fully transitioned into comedy development as the vehicle to achieve a cash-flow positive operation and to provide the best return on shareholder's investment.

Fletcher oversaw the production of 200 comedy specials for Season 1, and Season 2 begins taping in a few weeks. So far, 50 of the 200 shows have hit YouTube, resulting in more than 2 million views.

"We have built a pipeline of comedy specials that is attracting attention in the industry, and a significant audience on YouTube," Mr. Fletcher says. "Vyre will help us reach millions more."

The shows are filmed in the Comedy Cube, Funny Media Group's state-of-the-art facility in downtown Los Angeles. Shows are released on Mondays, Wednesdays, and Fridays.

Mr. Fletcher has an extensive background in production and media. He has owned his own production studio in Los Angeles for the past 20 years and has produced national shows for CNN, FOX, Food Network and Comedy Central, among others.

The short-term goal for Funny Media Group is to produce content for streaming services such as Netflix and Amazon with the long-term goal of building a large media catalog for acquisition.

Funny Media's comedy show content taped at the Comedy Cube:

https://www.youtube.com/c/FunnyMediaGroup

About Us

UMAX Group Corp. is a Nevada corporation, is a public-quoted Pink Sheet issuer under the ticker symbol "UMAX". UMAX reports as an alternative reporting issuer with OTC Markets Group, Inc. and is current in its mandatory required filings (E.g., "Pink Sheet Current").

Disclaimer Regarding Forward Looking Statements

Certain statements that we make may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning futurestrategic objectives, business prospects, anticipated savings, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions, demand for and pricing of our products, acquisitions and divestitures, anticipated results of litigation and regulatory developments or general economic conditions. In addition, words such as "believes," "expects," "anticipates," "intends," "plans," "estimates," "projects," "forecasts," and future or conditional verbs such as "will," "may," "could," "should," and "would," as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. Forward-looking statements are not guarantees, and they involve risks, uncertainties, and assumptions. Although we make such statements based on assumptions that we believe to be reasonable, there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements. We caution investors not to rely unduly on any forward-lookingstatements.

Company Information:

UMAX Group Corp.

2020 Bay Avenue

Los Angeles, California 90021

Website (FMG): https://funnymediagroup.com/

Website (FMS): https://BroadcastWest.com/

Instagram: https://www.instagram.com/funnymediagroupofficial/?hl=en

YouTube:https://www.youtube.com/c/FunnyMediaGroup

Investor Relations: Jack Zietz

Email: investors@umaxgrpcorp.com

SOURCE: Umax Group Corp

$MSBM Message from the President – MSB Global Capital Corp (OTCMarkets: PINK:MSBM)
New Products/Services Announcement | 02/18/2022
Message from the President MSB Global Capital Corp (OTCMarkets: PINK:MSBM)



MSB Global Capital Corp. consists of a team of professionals around the globe , providing global family office services in the U.S., the U.K. and certain offshore locations.



Our mandate is to prioritize the interests of our clients while maximizing our investors long term portfolio value; in order to achieve their investment goal; we are currently investigating various opportunities for the acquisition of operating assets by MSBM.



Our business blueprint consists of three main areas of focus:(1) Pre-IPO consultation, (2) family office services to high net worth clients globally; AND (3) providing solutions to enterprises in Fintech sector. We position the Company as a global business hub, serving customers in various markets including Canada, the United Kingdom and the United States.



About MSB Global Capital Corp

A Nevada corporation, MSB Global Capital Corp. (OTC Pink: MSBM) is currently investigating various opportunities for the acquisition of operating assets.

For further information regarding the company, please visithttps://www.msbglobalcapital.com

Contact email: info@msbglobalcapital.com

$MSBM Message from the President – MSB Global Capital Corp (OTCMarkets: PINK:MSBM)
New Products/Services Announcement | 02/18/2022
Message from the President MSB Global Capital Corp (OTCMarkets: PINK:MSBM)



MSB Global Capital Corp. consists of a team of professionals around the globe , providing global family office services in the U.S., the U.K. and certain offshore locations.



Our mandate is to prioritize the interests of our clients while maximizing our investors long term portfolio value; in order to achieve their investment goal; we are currently investigating various opportunities for the acquisition of operating assets by MSBM.



Our business blueprint consists of three main areas of focus:(1) Pre-IPO consultation, (2) family office services to high net worth clients globally; AND (3) providing solutions to enterprises in Fintech sector. We position the Company as a global business hub, serving customers in various markets including Canada, the United Kingdom and the United States.



About MSB Global Capital Corp

A Nevada corporation, MSB Global Capital Corp. (OTC Pink: MSBM) is currently investigating various opportunities for the acquisition of operating assets.

For further information regarding the company, please visithttps://www.msbglobalcapital.com

Contact email: info@msbglobalcapital.com

$CGLD Mars Mines Limited Commits to $500,000 Initial Working Capital for Buscar's Treasure Canyon Gold Mining Project
Press Release | 02/18/2022
Mars Mines Limited Commits to $500,000 Initial Working Capital for Buscar's Treasure Canyon Gold Mining Project
PR Newswire

BEVERLY HILLS, Calif., Feb. 18, 2022

BEVERLY HILLS, Calif., Feb. 18, 2022 /PRNewswire/ -- Buscar Company, Inc. (OTC-PINK: CGLD) announced today that JV Partner Mars Mines Limited (MML), a company with decades of experience in mining gold has committed in writing to an initial $500,000.00 in working capital dedicated solely to the Treasure Canyon project.

Company President, Thomas Heathman stated, "We recently completed a ten (10) year Production Agreement that includes an initial commitment of $500K by our JV Partner, Mars Mines Limited. This commitment illustrates a level of confidence by our new partner that mining and production at Treasure Canyon will be fruitful for both parties involved."

ABOUT BUSCAR COMPANY: Buscar Company is a mining operation that holds the rights to the Treasure Canyon Mining claims located in Plumas County, California. More recently, the company has also acquired ten additional claims in the Bucks Lake area of Northern California. Combined, Buscar company has a total of 800 acres of unpatented claims in Plumas National Forest, California.

Mr. Heathman finished up with, "The setbacks we experienced over the past several months are now behind us and in the rear view. This agreement and the initial investment into the company allows us to tap into the wealth of resources available via MML in order to move forward aggressively with the Treasure Canyon project. We look forward to sharing more with you in the coming weeks."

ABOUT MARS MINES LIMITED: Based in Australia, Mars Mines Limited has gold exploration and mining interests in Brazil, Ecuador, Nigeria and now California via its agreement to help oversee and conduct the mining operations at Treasure Canyon as a joint venture partner with Buscar Company.

FORWARD-LOOKING STATEMENTS

Notice Regarding Forward-Looking Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate.



Cision View original content:https://www.prnewswire.com/news-releases/mars-mines-limited-commits-to-500-000-initial-working-capital-for-buscars-treasure-canyon-gold-mining-project-301485529.html

$CGLD Mars Mines Limited Commits to $500,000 Initial Working Capital for Buscar's Treasure Canyon Gold Mining Project
Press Release | 02/18/2022
Mars Mines Limited Commits to $500,000 Initial Working Capital for Buscar's Treasure Canyon Gold Mining Project
PR Newswire

BEVERLY HILLS, Calif., Feb. 18, 2022

BEVERLY HILLS, Calif., Feb. 18, 2022 /PRNewswire/ -- Buscar Company, Inc. (OTC-PINK: CGLD) announced today that JV Partner Mars Mines Limited (MML), a company with decades of experience in mining gold has committed in writing to an initial $500,000.00 in working capital dedicated solely to the Treasure Canyon project.

Company President, Thomas Heathman stated, "We recently completed a ten (10) year Production Agreement that includes an initial commitment of $500K by our JV Partner, Mars Mines Limited. This commitment illustrates a level of confidence by our new partner that mining and production at Treasure Canyon will be fruitful for both parties involved."

ABOUT BUSCAR COMPANY: Buscar Company is a mining operation that holds the rights to the Treasure Canyon Mining claims located in Plumas County, California. More recently, the company has also acquired ten additional claims in the Bucks Lake area of Northern California. Combined, Buscar company has a total of 800 acres of unpatented claims in Plumas National Forest, California.

Mr. Heathman finished up with, "The setbacks we experienced over the past several months are now behind us and in the rear view. This agreement and the initial investment into the company allows us to tap into the wealth of resources available via MML in order to move forward aggressively with the Treasure Canyon project. We look forward to sharing more with you in the coming weeks."

ABOUT MARS MINES LIMITED: Based in Australia, Mars Mines Limited has gold exploration and mining interests in Brazil, Ecuador, Nigeria and now California via its agreement to help oversee and conduct the mining operations at Treasure Canyon as a joint venture partner with Buscar Company.

FORWARD-LOOKING STATEMENTS

Notice Regarding Forward-Looking Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate.



Cision View original content:https://www.prnewswire.com/news-releases/mars-mines-limited-commits-to-500-000-initial-working-capital-for-buscars-treasure-canyon-gold-mining-project-301485529.html

$SNNC SIBANNAC, INC. CEO JOINS “NEW TO THE STREET” ANCHOR JANE KING IN INTERVIEW
Press Release | 02/18/2022
Scottsdale, Arizona, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:

David Mersky, CEO of Sibannac, Inc., joins New to the Street anchor, Jane King, in an interview to discuss the Company’s entry into the alternative wellness space.

The interview will air on Newsmax on Sunday, February 20th at 10:00 AM EST and on Fox Business on Monday, February 21st at 10:30 PM PST.

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

$SNNC SIBANNAC, INC. CEO JOINS “NEW TO THE STREET” ANCHOR JANE KING IN INTERVIEW
Press Release | 02/18/2022
Scottsdale, Arizona, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:

David Mersky, CEO of Sibannac, Inc., joins New to the Street anchor, Jane King, in an interview to discuss the Company’s entry into the alternative wellness space.

The interview will air on Newsmax on Sunday, February 20th at 10:00 AM EST and on Fox Business on Monday, February 21st at 10:30 PM PST.

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

$EDVR Rebecca Humphries, Senior Vice President at Endeavor Bank, Elected as Chairperson of California Southern Small Business Development Corporation
Press Release | 02/17/2022
Rebecca Humphries, senior vice president at Endeavor Bank, has been elected by her peers at California Southern Small Business Development Corporation to chair its board. Her two-year term starts immediately.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220217005890/en/

Rebecca Humphries, Endeavor Bank Senior Vice President (Photo: Business Wire)
Rebecca Humphries, Endeavor Bank Senior Vice President (Photo: Business Wire)

Humphries will support the organization’s mission to secure financing for small businesses that have great potential but may not qualify for a conventional loan on their own.

“We are excited to have Rebecca as the elected Chair,” said Juan Carlos Hernandez, President and CEO of California Southern Small Business Development Corporation. “Her knowledge of The State Guarantee Loan Program has allowed for her to provide access to capital to various businesses. In addition, her leadership in the banking community has been a resource to expand our services across the State of California.”

California Southern SBDC is a non-profit chartered and regulated by the California Infrastructure and Economic Development Bank (I Bank) to provide loan guarantees to financial institutions. The State of California Small Business Loan Guarantee Program (SBLGP) is funded annually by the Governor of the State of California and is designed to help small businesses expand, grow, create, and retain jobs in California.

“As a banker, knowing how to use California Southern SBDC services helps me advise my clients about the best way forward to securing a loan,” said Humphries. “I’m proud to lead this organization and help spread the word about our value proposition.”

California Southern SBDC has longstanding and trusted relationships with more than 40 banks and lending institutions, including Endeavor Bank. The program places emphasis on assisting small businesses by assuming a portion of the financial risk, particularly for minority and women-owned businesses that may not be able to qualify for a bank loan without a guarantee.

“Rebecca is a great example of a true community banker,” said Endeavor Bank President Steve Sefton. “She understands the importance of a financial institution’s role in empowering the business community around it. I’m confident she will be a great leader for California Southern SBDC.”

Since 1989, California Southern SBDC has helped create more than 4,000 new jobs in a variety of industry sectors including construction, hospitality, ancillary medical services, service industry and craft brewing.

Humphries has served as a board member of California Southern SBDC for the past seven years. She also spent many years on the board of an East County San Diego youth sports organization. She is a resident of El Cajon, California.

About Endeavor Bank

Endeavor Bank is primarily owned and operated by San Diegans for San Diego businesses and their owners. The bank’s focus is local: local decision-making, local board, local founders, local owners, and relationships with local clients in the San Diego metropolitan marketplace and its surrounding areas.

Headquartered in downtown San Diego in the landmark Symphony Towers building, the Bank also operates a loan production and executive administration office in Carlsbad. Endeavor Bank provides traditional business banking services across a broad spectrum of industries and specialties. Unique to the bank is its consultative banking approach that partners business clients with Endeavor Bank’s senior management. Together, we build strategies and provide resources that solve problems, plan for the future and help clients’ efforts to grow revenues and profits. Visit www.bankendeavor.com for more information.

EDVR Shareholders

With many of our shareholders transferring their EDVR shares to their brokerage companies, along with ongoing trading taking place, the Bank may not have the most current shareholder contact information. If you are an EDVR shareholder and would like to receive information via a more timely method, please complete the Shareholder Communication Preference Form on our website: https://www.bankendeavor.com/investor-relations so we can keep you updated on EDVR news, and invite you to various shareholder networking events throughout the year.

Forward-Looking Statements

This press release includes “forward-looking statements,” as such term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on the current beliefs of the Bank’s directors and executive officers (collectively, “Management”), as well as assumptions made by and information currently available to the Bank’s Management. All statements regarding the Bank’s business strategy and plans and objectives of Management of the Bank for future operations, are forward-looking statements. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect” and “intend” and words or phrases of similar meaning, as they relate to the Bank or the Bank’s Management, are intended to identify forward-looking statements. Although the Bank believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from the Bank’s expectations (“cautionary statements”) are the effects of the COVID-19 pandemic and related government actions on the Bank and its customers, loan losses, changes in interest rates, loss of key personnel, lower lending limits and capital than competitors, regulatory restrictions and oversight of the Bank, the secure and effective implementation of technology, risks related to the local and national economy, the Bank's implementation of its business plans and management of growth, loan performance, interest rates, and regulatory matters, the effects of trade, monetary and fiscal policies, inflation, and changes in accounting policies and practices. Based upon changing conditions, if any one or more of these risks or uncertainties materialize, or if any underlying assumptions prove incorrect, actual results may vary materially from those described as anticipated, believed, estimated, expected, or intended. The Bank does not intend to update these forward-looking statements.

$BLLB Bell Buckle Holdings, Inc. Updates Shareholders and Enters into Discussions with Two Operating Companies
Press Release | 02/17/2022
Naples, FL, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Bell Buckle Holdings Inc. (OTC Pink: BLLB) (“The Company”) is pleased to update shareholders on our progress in 2022 and continues to execute on our long-term business plan.

First: The Company reported in the 2020-year end OTC Disclosure that Bell Buckle Holdings had signed an agreement to acquire nearly $20 Million of debt assets. The assets currently being evaluated are Merchant Cash Advance loans, personal loans, private student loans, real estate loans and other income producing portfolios.
The Company will partner with proven law firms, consultants, and debt collection agencies to turn these outstanding obligations into cash assets. The US debt market is currently comprised of $15 Trillion in various types of debt

“We will be able to purchase larger debt portfolios at steep discounts as part of our agreements -- 5-10 cents on the dollar. We foresee that we will be able to help small businesses and consumers in our economy resolve their obligations at a discount while realizing profitability for the Company’s shareholders,” Commented Kim Halvorson, Chief Executive Officer, Bell Buckle Holdings Inc.

Second: The Company is in discussions with two companies for a potential merger or acquisition. One is an online software company that provides law firms, debt buyers, collection agencies and other small businesses with state-of-the-art platforms and technology to manage their operations. The other is an artificial intelligence service.

“We believe the multi-billion debt resolution industry is ready to move forward and transition to the latest Artificial Intelligence and Case Management tools and that Bell Buckle will be poised to be on the forefront of that transition,” further commented Kim Halvorson, Chief Executive Officer of Bell Buckle, Inc.

Third: Bell Buckle, CEO Kim Halvorson, and Board Members Don Zeppenfeld and Robert Clegg have the experience, expertise, and knowledge to help scale and exponentially grow these two companies if a successful union can be achieved.

The Company will provide more information on all the above as material events occur and will update the shareholders as per OTC Markets best practices and guidelines.

ABOUT BELL BUCKLE HOLDINGS:
Bell Buckle Holdings is engaged in purchasing outstanding consumer loans and debt instruments. Bell Buckle Holdings seeks market and off-market assets for acquisition, resolution, and liquidation in the multi trillion-dollar US market. We use strategic partners, including law firms, collection agencies and consulting firms to maximize return on investment, increase enterprise assets.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Signed.
/S/ Ms. K Halvorson

FOR MORE INFORMATION, PLEASE CONTACT:

PR CONTACT: Kim Halvorson
5660 Strand Court: Unit #107
Naples, FL 34110
Email: info@bellbuckleholdings.com
Website: www.bellbuckleholdings.com

$BLLB Bell Buckle Holdings, Inc. Updates Shareholders and Enters into Discussions with Two Operating Companies
Press Release | 02/17/2022
Naples, FL, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Bell Buckle Holdings Inc. (OTC Pink: BLLB) (“The Company”) is pleased to update shareholders on our progress in 2022 and continues to execute on our long-term business plan.

First: The Company reported in the 2020-year end OTC Disclosure that Bell Buckle Holdings had signed an agreement to acquire nearly $20 Million of debt assets. The assets currently being evaluated are Merchant Cash Advance loans, personal loans, private student loans, real estate loans and other income producing portfolios.
The Company will partner with proven law firms, consultants, and debt collection agencies to turn these outstanding obligations into cash assets. The US debt market is currently comprised of $15 Trillion in various types of debt

“We will be able to purchase larger debt portfolios at steep discounts as part of our agreements -- 5-10 cents on the dollar. We foresee that we will be able to help small businesses and consumers in our economy resolve their obligations at a discount while realizing profitability for the Company’s shareholders,” Commented Kim Halvorson, Chief Executive Officer, Bell Buckle Holdings Inc.

Second: The Company is in discussions with two companies for a potential merger or acquisition. One is an online software company that provides law firms, debt buyers, collection agencies and other small businesses with state-of-the-art platforms and technology to manage their operations. The other is an artificial intelligence service.

“We believe the multi-billion debt resolution industry is ready to move forward and transition to the latest Artificial Intelligence and Case Management tools and that Bell Buckle will be poised to be on the forefront of that transition,” further commented Kim Halvorson, Chief Executive Officer of Bell Buckle, Inc.

Third: Bell Buckle, CEO Kim Halvorson, and Board Members Don Zeppenfeld and Robert Clegg have the experience, expertise, and knowledge to help scale and exponentially grow these two companies if a successful union can be achieved.

The Company will provide more information on all the above as material events occur and will update the shareholders as per OTC Markets best practices and guidelines.

ABOUT BELL BUCKLE HOLDINGS:
Bell Buckle Holdings is engaged in purchasing outstanding consumer loans and debt instruments. Bell Buckle Holdings seeks market and off-market assets for acquisition, resolution, and liquidation in the multi trillion-dollar US market. We use strategic partners, including law firms, collection agencies and consulting firms to maximize return on investment, increase enterprise assets.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Signed.
/S/ Ms. K Halvorson

FOR MORE INFORMATION, PLEASE CONTACT:

PR CONTACT: Kim Halvorson
5660 Strand Court: Unit #107
Naples, FL 34110
Email: info@bellbuckleholdings.com
Website: www.bellbuckleholdings.com

$ILUS OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Acquisition, Vira Drones, Confirms Pre-Order Discussions for One Hundred Vira M500 Unmanned Aerial Vehicles
Press Release | 02/17/2022
NEW YORK, NY, Feb. 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ILUS International Inc (OTC: ILUS) is a Mergers and Acquisitions company focused on acquiring and developing public safety technology-based companies across the globe. ILUS recently acquired Vira Drones, an Unmanned Aerial Vehicle (UAV) company based in Germany and Switzerland. Vira Drones develops and manufactures UAVs or Industrial Drones which provide the unmanned capability of light helicopters. Their revolutionary technology for the rescue and logistics sector has piqued interest from potential global customers and partners. ILUS can confirm that Vira Drones is now in pre-order discussions with a global company for one hundred Vira M500 rescue UAVs. The total order value being discussed is $60 million with a pre-order deposit of $6 million and delivery in the fourth quarter of 2023.

ILUS CEO, Nick Link, said: “Our teams are often in discussions regarding orders or taking pre-orders, therefore we had not originally considered publishing this news. In this case, we feel that even though it is highly likely that Vira Drones could receive this pre-order for 100 rescue drones, it is most important for our Shareholders and Interested Parties to visualize the extraordinary potential and value that exists within the Vira Drone business. Typical government or military organizations are looking to purchase more than 5 units at a time and Vira Drones has several opportunities in its pipeline for 10 or more units. Opportunities can be won or lost but we are thrilled by the demand for the Vira Drones technology and the number of customers and aviation partners who are interested in pre-ordering their solutions.”

Vira Drones, which was acquired by ILUS in January 2022, creates industrial heavy drones (UAVs) for the rescue, logistics and military sectors. With Vira Drones’ proprietary technology, their UAVs can carry loads of up to 1000kg for as long as two hours, making their UAVs a viable unmanned alternative to light helicopters and free of their limitations. The Vira Drones product range currently consists of the Vira M250, M500 and M750 which have a payload of 250kg, 500kg and 750kg respectively. The Vira M250 has a flight time of up to 4 hours and maximum speeds for the UAVs range from 125 to 150 km/h.

Vira Drones previously developed a rescue UAV concept model based on its M500 UAV to provide the capability to rescue victims from disaster sites such as in the event of flooding, wildfires, and structure fires (burning buildings). The concept UAV can transport various configurations of firefighting equipment, rescue equipment, and emergency supplies, or it can transport as many as 5 victims should they need rescuing. Having stepped up its business development efforts since its acquisition by ILUS, Vira Drones has been in multiple discussions with international organizations, government authorities and aviation companies regarding its full range of UAVs. As a result, the company is now in discussions for the pre-order of one hundred rescue UAVs and is also in further discussions with companies regarding pre-orders for its smaller M250 logistics UAV.

ILUS is currently focused on Vira Drone’s registration of patents and certifications whilst redesigning the company’s website and improving the overall marketing aspects of the business. On the production front, Vira Drones is beginning its production of three M250 drones which will be used for flying demonstrations and exhibitions. ILUS is also exploring available options for hydrogen powered technology as well as for automation software, either through partnership or acquisition.

“Since our acquisition by ILUS, we are accelerating all aspects of our business. We are pleased to see the interest in our technology from large global organizations and to be involved in promising discussions regarding several pre-orders, including for one hundred rescue drones. Our primary focus is the protection of our IP through the registering of patents and to build our first commercial flying drones.” - Valeriy Gorshkov, CEO of Vira Drones.

ILUS Managing Director, John-Paul Backwell, commented: “Since acquiring Vira Drones, we have been hard at work planning for the sustainable growth of the business. However, we have also been inundated with requirements for the technology. Vira Drones holds immeasurable potential for ILUS and its Shareholders, especially when one considers that several UAV companies have recently received billion-dollar valuations, despite having zero revenue or certifications and in most cases, not even a flying product. In the short-term we are driven towards the patent registrations, marketing improvements and the production of three M250 units for testing, demonstration and agreed proof of concepts with customers and aviation partners. Successful completion of this next phase will position Vira Drones for exponential growth and a substantial valuation, but we are most excited about seeing the technology being used to solve real world problems in disaster management, emergency response and public safety.”

For further information on the companies, please see their communication channels:

Website: https://ilus-group.com
Twitter: OTC_ILUS

Contact:

Email: IR@Ilus-Group.com

Source: ILUS

Related Links

https://ilus-group.com

Forward-Looking Statement
Certain information set forth in this press release contains "forward-looking information", including "future-oriented financial information" and "financial outlook", under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company's business, projects, and joint ventures; (iv) execution of the Company's vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company's projects; (vi) completion of the Company's projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company's current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management's beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements. Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. The Securities and Exchange Commission ("SEC") has provided guidance to issuers regarding the use of social media to disclose material non-public information. In this regard, investors and others should note that we announce material financial information via official Press Releases, in addition to SEC filings, press releases, Questions & Answers sessions, public conference calls and webcastsalso may take time from time to time. We use these channels as well as social media to communicate with the public about our company, our services, and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, considering the SEC's guidance, we encourage investors, the media, and others interested in our company to review the information we post on the following social & media channels:
website: https://ilus-group.com Twitter: OTC_ILUS
Note: ILUS Coin does not sit within ILUS International Inc (Ilustrato Pictures International Inc), so the public are recommended to follow the correct Media Channels relating to the public company OTC: ILUS.

$ILUS OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Acquisition, Vira Drones, Confirms Pre-Order Discussions for One Hundred Vira M500 Unmanned Aerial Vehicles
Press Release | 02/17/2022
NEW YORK, NY, Feb. 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ILUS International Inc (OTC: ILUS) is a Mergers and Acquisitions company focused on acquiring and developing public safety technology-based companies across the globe. ILUS recently acquired Vira Drones, an Unmanned Aerial Vehicle (UAV) company based in Germany and Switzerland. Vira Drones develops and manufactures UAVs or Industrial Drones which provide the unmanned capability of light helicopters. Their revolutionary technology for the rescue and logistics sector has piqued interest from potential global customers and partners. ILUS can confirm that Vira Drones is now in pre-order discussions with a global company for one hundred Vira M500 rescue UAVs. The total order value being discussed is $60 million with a pre-order deposit of $6 million and delivery in the fourth quarter of 2023.

ILUS CEO, Nick Link, said: “Our teams are often in discussions regarding orders or taking pre-orders, therefore we had not originally considered publishing this news. In this case, we feel that even though it is highly likely that Vira Drones could receive this pre-order for 100 rescue drones, it is most important for our Shareholders and Interested Parties to visualize the extraordinary potential and value that exists within the Vira Drone business. Typical government or military organizations are looking to purchase more than 5 units at a time and Vira Drones has several opportunities in its pipeline for 10 or more units. Opportunities can be won or lost but we are thrilled by the demand for the Vira Drones technology and the number of customers and aviation partners who are interested in pre-ordering their solutions.”

Vira Drones, which was acquired by ILUS in January 2022, creates industrial heavy drones (UAVs) for the rescue, logistics and military sectors. With Vira Drones’ proprietary technology, their UAVs can carry loads of up to 1000kg for as long as two hours, making their UAVs a viable unmanned alternative to light helicopters and free of their limitations. The Vira Drones product range currently consists of the Vira M250, M500 and M750 which have a payload of 250kg, 500kg and 750kg respectively. The Vira M250 has a flight time of up to 4 hours and maximum speeds for the UAVs range from 125 to 150 km/h.

Vira Drones previously developed a rescue UAV concept model based on its M500 UAV to provide the capability to rescue victims from disaster sites such as in the event of flooding, wildfires, and structure fires (burning buildings). The concept UAV can transport various configurations of firefighting equipment, rescue equipment, and emergency supplies, or it can transport as many as 5 victims should they need rescuing. Having stepped up its business development efforts since its acquisition by ILUS, Vira Drones has been in multiple discussions with international organizations, government authorities and aviation companies regarding its full range of UAVs. As a result, the company is now in discussions for the pre-order of one hundred rescue UAVs and is also in further discussions with companies regarding pre-orders for its smaller M250 logistics UAV.

ILUS is currently focused on Vira Drone’s registration of patents and certifications whilst redesigning the company’s website and improving the overall marketing aspects of the business. On the production front, Vira Drones is beginning its production of three M250 drones which will be used for flying demonstrations and exhibitions. ILUS is also exploring available options for hydrogen powered technology as well as for automation software, either through partnership or acquisition.

“Since our acquisition by ILUS, we are accelerating all aspects of our business. We are pleased to see the interest in our technology from large global organizations and to be involved in promising discussions regarding several pre-orders, including for one hundred rescue drones. Our primary focus is the protection of our IP through the registering of patents and to build our first commercial flying drones.” - Valeriy Gorshkov, CEO of Vira Drones.

ILUS Managing Director, John-Paul Backwell, commented: “Since acquiring Vira Drones, we have been hard at work planning for the sustainable growth of the business. However, we have also been inundated with requirements for the technology. Vira Drones holds immeasurable potential for ILUS and its Shareholders, especially when one considers that several UAV companies have recently received billion-dollar valuations, despite having zero revenue or certifications and in most cases, not even a flying product. In the short-term we are driven towards the patent registrations, marketing improvements and the production of three M250 units for testing, demonstration and agreed proof of concepts with customers and aviation partners. Successful completion of this next phase will position Vira Drones for exponential growth and a substantial valuation, but we are most excited about seeing the technology being used to solve real world problems in disaster management, emergency response and public safety.”

For further information on the companies, please see their communication channels:

Website: https://ilus-group.com
Twitter: OTC_ILUS

Contact:

Email: IR@Ilus-Group.com

Source: ILUS

Related Links

https://ilus-group.com

Forward-Looking Statement
Certain information set forth in this press release contains "forward-looking information", including "future-oriented financial information" and "financial outlook", under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company's business, projects, and joint ventures; (iv) execution of the Company's vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company's projects; (vi) completion of the Company's projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company's current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management's beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements. Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. The Securities and Exchange Commission ("SEC") has provided guidance to issuers regarding the use of social media to disclose material non-public information. In this regard, investors and others should note that we announce material financial information via official Press Releases, in addition to SEC filings, press releases, Questions & Answers sessions, public conference calls and webcastsalso may take time from time to time. We use these channels as well as social media to communicate with the public about our company, our services, and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, considering the SEC's guidance, we encourage investors, the media, and others interested in our company to review the information we post on the following social & media channels:
website: https://ilus-group.com Twitter: OTC_ILUS
Note: ILUS Coin does not sit within ILUS International Inc (Ilustrato Pictures International Inc), so the public are recommended to follow the correct Media Channels relating to the public company OTC: ILUS.

$ILUS OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Acquisition, Vira Drones, Confirms Pre-Order Discussions for One Hundred Vira M500 Unmanned Aerial Vehicles
Press Release | 02/17/2022
NEW YORK, NY, Feb. 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ILUS International Inc (OTC: ILUS) is a Mergers and Acquisitions company focused on acquiring and developing public safety technology-based companies across the globe. ILUS recently acquired Vira Drones, an Unmanned Aerial Vehicle (UAV) company based in Germany and Switzerland. Vira Drones develops and manufactures UAVs or Industrial Drones which provide the unmanned capability of light helicopters. Their revolutionary technology for the rescue and logistics sector has piqued interest from potential global customers and partners. ILUS can confirm that Vira Drones is now in pre-order discussions with a global company for one hundred Vira M500 rescue UAVs. The total order value being discussed is $60 million with a pre-order deposit of $6 million and delivery in the fourth quarter of 2023.

ILUS CEO, Nick Link, said: “Our teams are often in discussions regarding orders or taking pre-orders, therefore we had not originally considered publishing this news. In this case, we feel that even though it is highly likely that Vira Drones could receive this pre-order for 100 rescue drones, it is most important for our Shareholders and Interested Parties to visualize the extraordinary potential and value that exists within the Vira Drone business. Typical government or military organizations are looking to purchase more than 5 units at a time and Vira Drones has several opportunities in its pipeline for 10 or more units. Opportunities can be won or lost but we are thrilled by the demand for the Vira Drones technology and the number of customers and aviation partners who are interested in pre-ordering their solutions.”

Vira Drones, which was acquired by ILUS in January 2022, creates industrial heavy drones (UAVs) for the rescue, logistics and military sectors. With Vira Drones’ proprietary technology, their UAVs can carry loads of up to 1000kg for as long as two hours, making their UAVs a viable unmanned alternative to light helicopters and free of their limitations. The Vira Drones product range currently consists of the Vira M250, M500 and M750 which have a payload of 250kg, 500kg and 750kg respectively. The Vira M250 has a flight time of up to 4 hours and maximum speeds for the UAVs range from 125 to 150 km/h.

Vira Drones previously developed a rescue UAV concept model based on its M500 UAV to provide the capability to rescue victims from disaster sites such as in the event of flooding, wildfires, and structure fires (burning buildings). The concept UAV can transport various configurations of firefighting equipment, rescue equipment, and emergency supplies, or it can transport as many as 5 victims should they need rescuing. Having stepped up its business development efforts since its acquisition by ILUS, Vira Drones has been in multiple discussions with international organizations, government authorities and aviation companies regarding its full range of UAVs. As a result, the company is now in discussions for the pre-order of one hundred rescue UAVs and is also in further discussions with companies regarding pre-orders for its smaller M250 logistics UAV.

ILUS is currently focused on Vira Drone’s registration of patents and certifications whilst redesigning the company’s website and improving the overall marketing aspects of the business. On the production front, Vira Drones is beginning its production of three M250 drones which will be used for flying demonstrations and exhibitions. ILUS is also exploring available options for hydrogen powered technology as well as for automation software, either through partnership or acquisition.

“Since our acquisition by ILUS, we are accelerating all aspects of our business. We are pleased to see the interest in our technology from large global organizations and to be involved in promising discussions regarding several pre-orders, including for one hundred rescue drones. Our primary focus is the protection of our IP through the registering of patents and to build our first commercial flying drones.” - Valeriy Gorshkov, CEO of Vira Drones.

ILUS Managing Director, John-Paul Backwell, commented: “Since acquiring Vira Drones, we have been hard at work planning for the sustainable growth of the business. However, we have also been inundated with requirements for the technology. Vira Drones holds immeasurable potential for ILUS and its Shareholders, especially when one considers that several UAV companies have recently received billion-dollar valuations, despite having zero revenue or certifications and in most cases, not even a flying product. In the short-term we are driven towards the patent registrations, marketing improvements and the production of three M250 units for testing, demonstration and agreed proof of concepts with customers and aviation partners. Successful completion of this next phase will position Vira Drones for exponential growth and a substantial valuation, but we are most excited about seeing the technology being used to solve real world problems in disaster management, emergency response and public safety.”

For further information on the companies, please see their communication channels:

Website: https://ilus-group.com
Twitter: OTC_ILUS

Contact:

Email: IR@Ilus-Group.com

Source: ILUS

Related Links

https://ilus-group.com

Forward-Looking Statement
Certain information set forth in this press release contains "forward-looking information", including "future-oriented financial information" and "financial outlook", under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company's business, projects, and joint ventures; (iv) execution of the Company's vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company's projects; (vi) completion of the Company's projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company's current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management's beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements. Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. The Securities and Exchange Commission ("SEC") has provided guidance to issuers regarding the use of social media to disclose material non-public information. In this regard, investors and others should note that we announce material financial information via official Press Releases, in addition to SEC filings, press releases, Questions & Answers sessions, public conference calls and webcastsalso may take time from time to time. We use these channels as well as social media to communicate with the public about our company, our services, and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, considering the SEC's guidance, we encourage investors, the media, and others interested in our company to review the information we post on the following social & media channels:
website: https://ilus-group.com Twitter: OTC_ILUS
Note: ILUS Coin does not sit within ILUS International Inc (Ilustrato Pictures International Inc), so the public are recommended to follow the correct Media Channels relating to the public company OTC: ILUS.

$USMJ PURA Positions Farmersville Hemp As A Global Brand Targeting $18 Billion Market
Press Release | 02/16/2022
Dallas, Texas, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) today emphasized that the company’s new Farmersville Hemp brand is a global brand. PURA management pointed out that the U.S. today is only a small fraction of the global hemp market currently dominated by the Asia Pacific region.

Last year, PURA launched an initiative to expand the utilization of hemp worldwide under the brand name Farmersville Hemp.

PURA is building a co-op of hemp growers and processors to raise market awareness around the multitude of yet to be realized uses of hemp and build a brand name to benefit all co-op participants under the name Farmersville Hemp.

Today, PURA management points out that its co-op participants reach substantially includes global targets.

The industrial hemp industry, to include the portion of CBD exclusively from hemp, is anticipated to grow to $18 billion by 2026.

PURA management thinks this is a substantial underestimate because the industry has yet to recognize the multitude of ways hemp can be utilized.

The Sustainability Market is expected to expand from $9 billion reported in 2021 to over $41 billion by 2028.

PURA management believes the impact hemp can have on sustainability is not fully baked into the industrial hemp forecasts.

PURA anticipates generating $1 million in revenue in 2022 with the potential to reach $10 million in revenue this year. The $10 million revenue opportunity outlook is improving based on the recent progress of PURA’s co-op partners.

PURA published a 2022 strategic overview at the onset of this year detailing the company’s plan to grow revenue and increase shareholder value by driving market wide demand for the “multitude of yet to be realized uses of hemp.”

Next week, On Tuesday, February 22nd, PURA management will publish its first progress update report on the execution of its strategic plan specifically focusing on the progress of the co-op partners that is improving PURA’s 2022 revenue outlook.

PURA co-op partners include Alkame Holdings, Inc. (OTC Pink: ALKM), PAO Group, Inc. (OTC Pink: PAOG), North American Cannabis Holdings, Inc. (OTC Pink: USMJ), and UC Asset LP (OTCQX: UCASU).

For more information on Puration, visit http://www.purationinc.com

Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.

For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

$USMJ PURA Positions Farmersville Hemp As A Global Brand Targeting $18 Billion Market
Press Release | 02/16/2022
Dallas, Texas, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) today emphasized that the company’s new Farmersville Hemp brand is a global brand. PURA management pointed out that the U.S. today is only a small fraction of the global hemp market currently dominated by the Asia Pacific region.

Last year, PURA launched an initiative to expand the utilization of hemp worldwide under the brand name Farmersville Hemp.

PURA is building a co-op of hemp growers and processors to raise market awareness around the multitude of yet to be realized uses of hemp and build a brand name to benefit all co-op participants under the name Farmersville Hemp.

Today, PURA management points out that its co-op participants reach substantially includes global targets.

The industrial hemp industry, to include the portion of CBD exclusively from hemp, is anticipated to grow to $18 billion by 2026.

PURA management thinks this is a substantial underestimate because the industry has yet to recognize the multitude of ways hemp can be utilized.

The Sustainability Market is expected to expand from $9 billion reported in 2021 to over $41 billion by 2028.

PURA management believes the impact hemp can have on sustainability is not fully baked into the industrial hemp forecasts.

PURA anticipates generating $1 million in revenue in 2022 with the potential to reach $10 million in revenue this year. The $10 million revenue opportunity outlook is improving based on the recent progress of PURA’s co-op partners.

PURA published a 2022 strategic overview at the onset of this year detailing the company’s plan to grow revenue and increase shareholder value by driving market wide demand for the “multitude of yet to be realized uses of hemp.”

Next week, On Tuesday, February 22nd, PURA management will publish its first progress update report on the execution of its strategic plan specifically focusing on the progress of the co-op partners that is improving PURA’s 2022 revenue outlook.

PURA co-op partners include Alkame Holdings, Inc. (OTC Pink: ALKM), PAO Group, Inc. (OTC Pink: PAOG), North American Cannabis Holdings, Inc. (OTC Pink: USMJ), and UC Asset LP (OTCQX: UCASU).

For more information on Puration, visit http://www.purationinc.com

Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.

For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

$INND InnerScope Hearing Technologies (OTC: INND) Launches New eCommerce Website for Subsidiary HearingAssist.com
Press Release | 02/16/2022
ROSEVILLE, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Direct-to-Consumer Hearing Technology space, today announced the launching of a new eCommerce website for HearingAssist, a wholly-owned subsidiary of InnerScope, located at https://hearingassist.com/. HearingAssist has been an established leader in the direct-to-consumer hearing aid market since 2008 and is Walmart's largest hearing aid supplier with product displays in 757 Walmart stores and over 500,000 hearing aids sold to date.

The new HearingAssist website showcases a transformative redesign that offers an industry-leading digital experience with a new eCommerce platform that features many creative redesigns, including mobile responsiveness for a better customer experience, enhanced search, a streamlined product search capability including live inventory and pricing search features, 24/7 product purchases with an easier check-out process, and scalability for HearingAssist's future growth improvements. Moreover, the new website empowers HearingAssist and the InnerScope team to manage content, launch marketing campaigns, maintain product data, and add features.

In addition, visitors to the website can click on the HearingAssist's 1-800-700-4327 phone number to automatically call and connect to one of HearingAssist's Hearing Product Specialists and receive a Free Consultation with one of a team of licensed hearing professionals to help answer any questions about their hearing loss and any hearing products requirements they may need.

Matthew Moore, President and CEO of InnerScope, commented: "I am thrilled to announce HearingAssist's new website, which provides us greater opportunities for growth by helping our existing customers and reaching potential new customers. Considerable thought and time have gone into the front and back-end of this new website. We designed this new website to provide hundreds of thousands of HearingAssist's current customers and potentially millions more, a robust, user-friendly experience where they have 24/7 access to the HearingAssist affordable hearing aids and related accessories as well as Free Consultation with one of our licensed Hearing Professionals."

HearingAssist's New Website Can Be Viewed At HearingAssist.com.

About InnerScope Hearing Technologies, Inc. (OTC PINK: INND):

InnerScope Hearing Technologies Inc. is a leading Direct-to-Consumer (DTC) manufacturer and distributor of FDA-registered hearing aids, hearing assistive devices, hearing health-related products, and Personal Sound Amplifier Products (PSAPs) ("Hearing Products") dedicated to addressing the global demand for affordable hearing solutions. InnerScope's Hearing Products and its business model break through the persistent barriers that prevent access to effective hearing solutions.

InnerScope's recent acquisition of iHear Medical Inc., a DTC cloud-based hearing solution provider, gives the Company access to over 40 patents and an FDA-registered manufacturing and R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader in the direct-to-consumer hearing aid market with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the direct-to-consumer hearing solutions market by selling advanced hearing products through Walmart and other major retailers.

InnerScope's full line of Hearing Health products is currently available through these multiple retail/wholesale channels: Walmart.com, Amazon.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, and Cardinal Health dba RGH Enterprises Inc. Additional major retailers in-store and online are launching soon.

For information related to InnerScope Hearing Technologies latest hearing aids and related hearing products, please visit:

http://iheardirect.com

http://hearingassist.com

For the most up-to-date information about InnerScope Hearing Technologies (OTC: INND), please visit and follow our official Twitter account @inndstock page:

https://twitter.com/inndstock

InnerScope Hyperlinks:

HearingAssist

hearing assist - Walmart.com

Acquisition of iHear Medical Inc.

Acquisition of HearingAssist

Direct-to-Consumer Hearing Products.

InnerScope's Hearing Health Flexible Subscription Plans

Safe Harbor

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended intended to be covered by the "safe harbor" created by those sections. Any statements that are not historical facts contained in this press release are also "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA). Such statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be canceled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing or maintain contractual relationships with vendors and customers, competition, general economic conditions and other factors that are detailed in our periodic reports filed with the Securities and Exchange Commission ("S.E.C."). We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA, Securities Act, and Securities Exchange Act.

Contact:

InnerScope Hearing Technologies, Inc.

Investor Relations

ir@innd.com

833-788-0506

www.innd.com

Investor Relations Agency Contact:

Skyline Corporate Communications Group, LLC
Lisa Gray, Senior Account Manager

One Rockefeller Plaza, 11th Floor
New York, NY 10020
Office: (646) 893-5835
Email: lisa@skylineccg.com

For the most up-to-date information about InnerScope Hearing Technologies (OTC: INND), please visit and follow our official Twitter account @inndstock page.

Wire Service Contact
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com

$INND InnerScope Hearing Technologies (OTC: INND) Launches New eCommerce Website for Subsidiary HearingAssist.com
Press Release | 02/16/2022
ROSEVILLE, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Direct-to-Consumer Hearing Technology space, today announced the launching of a new eCommerce website for HearingAssist, a wholly-owned subsidiary of InnerScope, located at https://hearingassist.com/. HearingAssist has been an established leader in the direct-to-consumer hearing aid market since 2008 and is Walmart's largest hearing aid supplier with product displays in 757 Walmart stores and over 500,000 hearing aids sold to date.

The new HearingAssist website showcases a transformative redesign that offers an industry-leading digital experience with a new eCommerce platform that features many creative redesigns, including mobile responsiveness for a better customer experience, enhanced search, a streamlined product search capability including live inventory and pricing search features, 24/7 product purchases with an easier check-out process, and scalability for HearingAssist's future growth improvements. Moreover, the new website empowers HearingAssist and the InnerScope team to manage content, launch marketing campaigns, maintain product data, and add features.

In addition, visitors to the website can click on the HearingAssist's 1-800-700-4327 phone number to automatically call and connect to one of HearingAssist's Hearing Product Specialists and receive a Free Consultation with one of a team of licensed hearing professionals to help answer any questions about their hearing loss and any hearing products requirements they may need.

Matthew Moore, President and CEO of InnerScope, commented: "I am thrilled to announce HearingAssist's new website, which provides us greater opportunities for growth by helping our existing customers and reaching potential new customers. Considerable thought and time have gone into the front and back-end of this new website. We designed this new website to provide hundreds of thousands of HearingAssist's current customers and potentially millions more, a robust, user-friendly experience where they have 24/7 access to the HearingAssist affordable hearing aids and related accessories as well as Free Consultation with one of our licensed Hearing Professionals."

HearingAssist's New Website Can Be Viewed At HearingAssist.com.

About InnerScope Hearing Technologies, Inc. (OTC PINK: INND):

InnerScope Hearing Technologies Inc. is a leading Direct-to-Consumer (DTC) manufacturer and distributor of FDA-registered hearing aids, hearing assistive devices, hearing health-related products, and Personal Sound Amplifier Products (PSAPs) ("Hearing Products") dedicated to addressing the global demand for affordable hearing solutions. InnerScope's Hearing Products and its business model break through the persistent barriers that prevent access to effective hearing solutions.

InnerScope's recent acquisition of iHear Medical Inc., a DTC cloud-based hearing solution provider, gives the Company access to over 40 patents and an FDA-registered manufacturing and R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader in the direct-to-consumer hearing aid market with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the direct-to-consumer hearing solutions market by selling advanced hearing products through Walmart and other major retailers.

InnerScope's full line of Hearing Health products is currently available through these multiple retail/wholesale channels: Walmart.com, Amazon.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, and Cardinal Health dba RGH Enterprises Inc. Additional major retailers in-store and online are launching soon.

For information related to InnerScope Hearing Technologies latest hearing aids and related hearing products, please visit:

http://iheardirect.com

http://hearingassist.com

For the most up-to-date information about InnerScope Hearing Technologies (OTC: INND), please visit and follow our official Twitter account @inndstock page:

https://twitter.com/inndstock

InnerScope Hyperlinks:

HearingAssist

hearing assist - Walmart.com

Acquisition of iHear Medical Inc.

Acquisition of HearingAssist

Direct-to-Consumer Hearing Products.

InnerScope's Hearing Health Flexible Subscription Plans

Safe Harbor

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended intended to be covered by the "safe harbor" created by those sections. Any statements that are not historical facts contained in this press release are also "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA). Such statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be canceled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing or maintain contractual relationships with vendors and customers, competition, general economic conditions and other factors that are detailed in our periodic reports filed with the Securities and Exchange Commission ("S.E.C."). We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA, Securities Act, and Securities Exchange Act.

Contact:

InnerScope Hearing Technologies, Inc.

Investor Relations

ir@innd.com

833-788-0506

www.innd.com

Investor Relations Agency Contact:

Skyline Corporate Communications Group, LLC
Lisa Gray, Senior Account Manager

One Rockefeller Plaza, 11th Floor
New York, NY 10020
Office: (646) 893-5835
Email: lisa@skylineccg.com

For the most up-to-date information about InnerScope Hearing Technologies (OTC: INND), please visit and follow our official Twitter account @inndstock page.

Wire Service Contact
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com

$ZAAG Za Group Subsidiary, NFID, Announces New Sustainable Limited-Edition Active Lifestyle Brand
Press Release | 02/16/2022
Za Group Subsidiary, NFID, Announces New Sustainable Limited-Edition Active Lifestyle Brand
Sustainable collection to be sold at online store
PR Newswire

PENSACOLA, Fla., Feb. 16, 2022

PENSACOLA, Fla., Feb. 16, 2022 /PRNewswire/ -- ZA Group Inc (ZAAG) announces its subsidiary NFID is ready to launch a new and first sustainable collection active lifestyle brand. NFID is an active lifestyle brand. The brand's history is rooted in the expansion of consciousness and targeted to consumers at the intersection of surf, skate, trail running, yoga, meditation, and martial art cultures. NFID is a direct-to-consumer brand that produces apparel and accessories available at www.NFID.com. ZA Group is pleased to announce the company is working with high end designers and manufacturers of sustainable products in order to release this new sustainable collection active lifestyle brand.

Furthermore, ZA Group looks to update the market in the coming days in regards to NFID and other matters as well as a new upscale acquisition & merger deal that it recently said it was working on via its social media account.

Sustainability improves the quality of our lives, protects our ecosystem and preserves natural resources for future generations" This is our first step in exploring how we can a positive impact to do our part" stated Bill Bollander. We are committed to looking at further ways to improve our systems and processes to make a difference.

About Us

ZA Group Inc. is a brand development company focused on acquiring direct to consumer (DTC) brands that deliver compelling products in fashion, street, wellness, home, active and outdoor lifestyle sectors. Our goal is to take these brands to the next level whether we own, license or manage them.

Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed in this press release may contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.

Cision View original content:https://www.prnewswire.com/news-releases/za-group-subsidiary-nfid-announces-new-sustainable-limited-edition-active-lifestyle-brand-301483581.html

$CYIO CYIOS CORP, WHOLLY OWNED SUBSIDIARY IMMORTALS GROUP SIGNS EXCLUSIVE AGREEMENT WITH STAN LEE HOLDINGS HK FOR HISTORIC NFT COLLECTION OF A “LOST” STAN LEE-WILL MEUGNIOT SUPERHERO FRANCHISE
Press Release | 02/16/2022
Boca Raton, Florida, Feb. 16, 2022 (GLOBE NEWSWIRE) -- CYIOS Corp: (OTC PINK: CYIO), a publicly traded holding company with subsidiary business focused on crypto-lending, crypto-trading and NFT’s today announced that its wholly owned subsidiary Immortals Group Pty has signed an exclusive development and distribution agreement with Stan Lee Holdings Ltd. of Hong Kong to produce and market Superhero NFT collectables. The partnership is commencing with a never before released Superhero character franchise created in 2000 by legendary Marvel comic creator Stan Lee and Marvel animation legend Will Meugniot. The global promotion of this historic Superhero NFT collection will conclude with an NFT drop scheduled for April. The website for the NFT collection is expected to go live this month and will provide in depth detail of the collection, its history, and the comic book legends involved with the project.

Mr. John O’Shea, Chairman of Cyios Corp commented, “We are thrilled to be working alongside some of the most noteworthy, iconic names in the world of superhero entertainment under an exclusive agreement with Stan Lee Holdings. This includes our working directly with Mr. Shirrel Rhoades, Director of Stan Lee Holdings Ltd. and owner of a historic library of never-before-released Stan Lee creations – superheroes, super villains, webisodes, and other digital entertainment produced for the dawn of the Internet Age (1999 – 2001). These rare Intellectual Properties are being curated by Mr. Rhoades for NFTs, NFT gaming, the Metaverse and other global entertainment platforms. Mr. Rhoades has a long history and track record of success in the publishing world as writer, publisher, author, filmmaker, syndicated film critic, comics scholar, comics historian, former college professor and former museum president. He is perhaps most well-known as the former Executive Vice President of Marvel Entertainment and the executive that Stan Lee personally handpicked to succeed him as Publisher of Marvel.”

“Our collaboration with Stan Lee Holdings is intended to develop numerous branded Superhero collections of NFT digital art collectibles with utility, the minting of individual super-hero characters, along with IP rights for future commercial use, and developing a P2E NFT game based on the franchise characters. A new website dedicated specifically for this upcoming NFT launch is expected to go live this month, which will provide project details including the NFT artist and co-creator with Stan Lee, the rich history and back-story of how this Superhero came to be and to remain unknown to the global audience of Superhero fans,” continued Mr. O’Shea.

Mr. Shirrel Rhoades, Director of Stan Lee Holdings commented, “We are excited about our collaboration with the CYIOS team and look forward to what should be the most important NFT Superhero drop yet to be offered. The discovery of a long-lost Stan Lee created parody sequel to Spider Man will amaze and attract Superhero fans around the world interested in owning an NFT of this long-hidden treasure.”

CONTACT INFORMATION
Public and Investor Relations: admin@cyioscorporation.com
Investors are encouraged to follow CYIOS using: www.twitter.com/cyioscorp
Follow Helio Lending: https://heliolending.com/ https://twitter.com/heliolending

About CYIOS Corporation
CYIOS Corporation is a publicly traded holding company with subsidiary businesses Helio Lending and Choice Wellness Inc. Through these subsidiaries, the Company is focused on cryptocurrency lending through Helio’s CeFi Aggregator platform, and Choice Wellness is focused on developing and marketing specialty branded products in the Health and Wellness markets, including the "DR’s CHOICE" and "24" brand of products. The team has in-depth knowledge of the health and wellness markets, financial services industry, medical and health services, and blockchain. The Company looks to develop, distribute, and license proprietary products as well as evaluate potential acquisition opportunities. Further, the Company continues to seek and evaluate attractive business opportunities and to leverage its resources and expertise to build a diversified, sustainable business model. For more information, please visit www.cyioscorporation.com

About Helio Lending, PTY LTD
Founded in 2018, Helio Lending has developed a CeFi cryptocurrency lending platform, with headquarters in Australia. Recognized as the first to market in Australia, Helio Lending was the first independent crypto lending company to actively lend within Australia. Helio has since evolved and positioned itself as the first CeFi (centralized finance) aggregator worldwide. Helio has a large panel of partners providing access to the best rates and offers for crypto loan providers as well as offering a competitive yield generating platform. Helio Lending provides holders of cryptocurrency (such as Bitcoin, Bitcoin Cash, Ethereum, Litecoin and Ripple) with a safe and secure way to access fiat funds at the best rates, without selling any of their cryptocurrency.

About ChoiceWellness, Inc.
ChoiceWellness, Inc. is a health and wellness company that has brought to market the DR’s CHOICE line of products, as well as the “24” Brand Hand Sanitizer products. DR’s CHOICE was developed with a mission to offer Doctors and Medical Practitioners their own Professional Grade CBD BRAND with a suite of products they could stand behind and be confident to offer to their patients. Our customers can be assured that DR’s CHOICE CBD products have gone through the highest scrutiny of testing for purity, potency, and quality. DR’s Choice products have been brought to market for Doctors and Medical Professionals seeking a better solution for patients suffering from pain, inflammation, anxiety, or other persistent symptoms. For more information, please visit www.choicewellnessbrands.com or email us at info@choicewellnessbrands.com.

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements.” Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified using words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" & other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered w/ these factors in mind. We assume no obligation to update any forward-looking statements contained in this report

$CYIO CYIOS CORP, WHOLLY OWNED SUBSIDIARY IMMORTALS GROUP SIGNS EXCLUSIVE AGREEMENT WITH STAN LEE HOLDINGS HK FOR HISTORIC NFT COLLECTION OF A “LOST” STAN LEE-WILL MEUGNIOT SUPERHERO FRANCHISE
Press Release | 02/16/2022
Boca Raton, Florida, Feb. 16, 2022 (GLOBE NEWSWIRE) -- CYIOS Corp: (OTC PINK: CYIO), a publicly traded holding company with subsidiary business focused on crypto-lending, crypto-trading and NFT’s today announced that its wholly owned subsidiary Immortals Group Pty has signed an exclusive development and distribution agreement with Stan Lee Holdings Ltd. of Hong Kong to produce and market Superhero NFT collectables. The partnership is commencing with a never before released Superhero character franchise created in 2000 by legendary Marvel comic creator Stan Lee and Marvel animation legend Will Meugniot. The global promotion of this historic Superhero NFT collection will conclude with an NFT drop scheduled for April. The website for the NFT collection is expected to go live this month and will provide in depth detail of the collection, its history, and the comic book legends involved with the project.

Mr. John O’Shea, Chairman of Cyios Corp commented, “We are thrilled to be working alongside some of the most noteworthy, iconic names in the world of superhero entertainment under an exclusive agreement with Stan Lee Holdings. This includes our working directly with Mr. Shirrel Rhoades, Director of Stan Lee Holdings Ltd. and owner of a historic library of never-before-released Stan Lee creations – superheroes, super villains, webisodes, and other digital entertainment produced for the dawn of the Internet Age (1999 – 2001). These rare Intellectual Properties are being curated by Mr. Rhoades for NFTs, NFT gaming, the Metaverse and other global entertainment platforms. Mr. Rhoades has a long history and track record of success in the publishing world as writer, publisher, author, filmmaker, syndicated film critic, comics scholar, comics historian, former college professor and former museum president. He is perhaps most well-known as the former Executive Vice President of Marvel Entertainment and the executive that Stan Lee personally handpicked to succeed him as Publisher of Marvel.”

“Our collaboration with Stan Lee Holdings is intended to develop numerous branded Superhero collections of NFT digital art collectibles with utility, the minting of individual super-hero characters, along with IP rights for future commercial use, and developing a P2E NFT game based on the franchise characters. A new website dedicated specifically for this upcoming NFT launch is expected to go live this month, which will provide project details including the NFT artist and co-creator with Stan Lee, the rich history and back-story of how this Superhero came to be and to remain unknown to the global audience of Superhero fans,” continued Mr. O’Shea.

Mr. Shirrel Rhoades, Director of Stan Lee Holdings commented, “We are excited about our collaboration with the CYIOS team and look forward to what should be the most important NFT Superhero drop yet to be offered. The discovery of a long-lost Stan Lee created parody sequel to Spider Man will amaze and attract Superhero fans around the world interested in owning an NFT of this long-hidden treasure.”

CONTACT INFORMATION
Public and Investor Relations: admin@cyioscorporation.com
Investors are encouraged to follow CYIOS using: www.twitter.com/cyioscorp
Follow Helio Lending: https://heliolending.com/ https://twitter.com/heliolending

About CYIOS Corporation
CYIOS Corporation is a publicly traded holding company with subsidiary businesses Helio Lending and Choice Wellness Inc. Through these subsidiaries, the Company is focused on cryptocurrency lending through Helio’s CeFi Aggregator platform, and Choice Wellness is focused on developing and marketing specialty branded products in the Health and Wellness markets, including the "DR’s CHOICE" and "24" brand of products. The team has in-depth knowledge of the health and wellness markets, financial services industry, medical and health services, and blockchain. The Company looks to develop, distribute, and license proprietary products as well as evaluate potential acquisition opportunities. Further, the Company continues to seek and evaluate attractive business opportunities and to leverage its resources and expertise to build a diversified, sustainable business model. For more information, please visit www.cyioscorporation.com

About Helio Lending, PTY LTD
Founded in 2018, Helio Lending has developed a CeFi cryptocurrency lending platform, with headquarters in Australia. Recognized as the first to market in Australia, Helio Lending was the first independent crypto lending company to actively lend within Australia. Helio has since evolved and positioned itself as the first CeFi (centralized finance) aggregator worldwide. Helio has a large panel of partners providing access to the best rates and offers for crypto loan providers as well as offering a competitive yield generating platform. Helio Lending provides holders of cryptocurrency (such as Bitcoin, Bitcoin Cash, Ethereum, Litecoin and Ripple) with a safe and secure way to access fiat funds at the best rates, without selling any of their cryptocurrency.

About ChoiceWellness, Inc.
ChoiceWellness, Inc. is a health and wellness company that has brought to market the DR’s CHOICE line of products, as well as the “24” Brand Hand Sanitizer products. DR’s CHOICE was developed with a mission to offer Doctors and Medical Practitioners their own Professional Grade CBD BRAND with a suite of products they could stand behind and be confident to offer to their patients. Our customers can be assured that DR’s CHOICE CBD products have gone through the highest scrutiny of testing for purity, potency, and quality. DR’s Choice products have been brought to market for Doctors and Medical Professionals seeking a better solution for patients suffering from pain, inflammation, anxiety, or other persistent symptoms. For more information, please visit www.choicewellnessbrands.com or email us at info@choicewellnessbrands.com.

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements.” Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified using words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" & other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered w/ these factors in mind. We assume no obligation to update any forward-looking statements contained in this report

$SLDX Stella Diagnostics Named ‘Best Clinical Proteomics Solution’ of 2021 by Biotech Breakthrough Awards
Press Release | 02/16/2022
SALT LAKE CITY, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient management strategies for precancerous and cancerous esophageal diseases, today announced its STLA101 mass spec proteomic assay (BEsmart™) was selected as the winner of the “Best Clinical Proteomics Solution of the Year” award for 2021 in the inaugural awards program conducted by BioTech Breakthrough. This year’s program attracted more than 1,200 nominations from over 12 different countries throughout the world.

Dr. Joe Abdo, CEO of Stella Diagnostics, said, “We are very grateful to have Stella Diagnostics' novel STLA101 assay recognized by BioTech Breakthrough for its massive potential clinical utility. Rather than rest on our accolades, this award will serve as motivation for our team to remain steadfast in attaining clinical adoption of STLA101 as a first-line diagnostic tool for patients receiving endoscopies for Barrett’s esophagus. This award supports our mission that providing more robust molecular data of diseased esophageal tissue compared to the current standard of care is a clinical need in gastroenterology.”

Dr. Abdo continued, “Esophageal cancer is currently the fastest rising, deadliest cancer in the U.S. As a two-time cancer survivor, I plan to do all I can to improve the patient management strategies for the millions of people living with precancerous esophageal disease. Using targeted mass spectrometry proteomics, we believe that informing physicians of the expression patterns playing a role in the pathogenesis of GERD, Barrett's esophagus and esophageal cancer early in the treatment plan may extend or save lives.”

Stella Diagnostics is working to see beyond routine gross and microscopic screening of esophageal diseases to better inform gastroenterologists, oncologists and pathologists of the molecular expression trends indicative of disease stability, progression and/or carcinogenesis. Esophageal adenocarcinoma arises from dysplastic tissue of Barrett's esophagus, a complication of gastroesophageal reflux disease (GERD), and is the fastest increasing cancer in the United States with a 600% increase over the past 25 years. Esophageal adenocarcinoma, which is linked to Barrett's esophagus, has one of the highest mortality rates in oncology, as more than 80% of patients diagnosed with esophageal adenocarcinoma have already progressed to advanced-stage cancer at the time of diagnosis. Stella Diagnostics’ mass spectroscopy-based proteomic assay, STLA101, offers physicians insight into the molecular properties of their patients’ tissue to determine if the disease is stable, progressing or turning cancerous.

Stella Diagnostics’ assay works in concert with current routine screening sequences to inform physicians of the biomarkers playing a role in the pathogenesis of GERD, Barrett's esophagus, and esophageal cancer. The company is currently undergoing optimization on its BEsmart™ proteomic panel (STLA101) in partnership with mProbe, Inc., and has multiple collaborative research agreements with leading institutions around the U.S., including the Mayo Clinic and Kansas University Medical Center, to assess assay performance of the BEsmart™ Test.

BioTech Breakthrough is a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe. The mission of the annual BioTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the top technology companies, solutions, and products in the life sciences and biotechnology industry today.

About Stella Diagnostics

Stella Diagnostics, Inc. is a molecular diagnostics-based organization focused on improving patient management strategies for over 60 million people living with severe esophageal disease. Stella Diagnostics’ clinical assay will offer physicians insight into the molecular properties of their patients' tissue to determine if the disease is stable, progressing or turning cancerous. Using targeted mass spectrometry proteomics, we believe that informing physicians of the expression patterns playing a role in the pathogenesis of GERD, Barrett's esophagus and esophageal cancer early in the treatment plan may extend or save lives. For more information, please visit www.stelladx.com.

Forward Looking Statements

Certain statements made in this press release are "forward looking statements" that are based on Stella Diagnostics' beliefs, assumptions, current expectations, estimates and projections. Forward looking statements involve known and unknown risks and uncertainties that may cause forecasted results to differ from actual results. Such risks include, but are not limited to market conditions, competitive factors, the ability to complete the proposed transaction and other such related risks. Stella Diagnostics can give no assurances that any projections related to revenues, profit margins or profits will be realized. Statements that are not historical fact, including without limitation statements which are preceded by, followed by or include the words "believes," "anticipates," "plans," "expects," "estimates," "may," "should," "intends," or similar expressions are forward looking statements. While Stella Diagnostics believes these assumptions, expectations, estimates, and projections are reasonable, such statements are subject to risks and uncertainties, certain of which are beyond our control and therefore, actual results may differ materially. Stella Diagnostics believes that many of the risks detailed here are part of doing business in the industry in which we would operate and compete. Forward looking statements only speak as of the date hereof and we do not undertake and expressly disclaim any obligation to update or release any revisions to any forward-looking statement whether as a result of new information, future events or otherwise except as required by law. While we believe the information used in this press release to be reliable, its accuracy has not been independently verified and cannot be guaranteed. Stella Diagnostics can give no assurances that any projections related to revenues, profit margins or profits will be realized.

Investors and Media Contact:

David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: info@stelladx.com
Skype: kugsusa
LinkedIn: https://www.linkedin.com/in/davidkugelman

$SLDX Stella Diagnostics Named ‘Best Clinical Proteomics Solution’ of 2021 by Biotech Breakthrough Awards
Press Release | 02/16/2022
SALT LAKE CITY, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient management strategies for precancerous and cancerous esophageal diseases, today announced its STLA101 mass spec proteomic assay (BEsmart™) was selected as the winner of the “Best Clinical Proteomics Solution of the Year” award for 2021 in the inaugural awards program conducted by BioTech Breakthrough. This year’s program attracted more than 1,200 nominations from over 12 different countries throughout the world.

Dr. Joe Abdo, CEO of Stella Diagnostics, said, “We are very grateful to have Stella Diagnostics' novel STLA101 assay recognized by BioTech Breakthrough for its massive potential clinical utility. Rather than rest on our accolades, this award will serve as motivation for our team to remain steadfast in attaining clinical adoption of STLA101 as a first-line diagnostic tool for patients receiving endoscopies for Barrett’s esophagus. This award supports our mission that providing more robust molecular data of diseased esophageal tissue compared to the current standard of care is a clinical need in gastroenterology.”

Dr. Abdo continued, “Esophageal cancer is currently the fastest rising, deadliest cancer in the U.S. As a two-time cancer survivor, I plan to do all I can to improve the patient management strategies for the millions of people living with precancerous esophageal disease. Using targeted mass spectrometry proteomics, we believe that informing physicians of the expression patterns playing a role in the pathogenesis of GERD, Barrett's esophagus and esophageal cancer early in the treatment plan may extend or save lives.”

Stella Diagnostics is working to see beyond routine gross and microscopic screening of esophageal diseases to better inform gastroenterologists, oncologists and pathologists of the molecular expression trends indicative of disease stability, progression and/or carcinogenesis. Esophageal adenocarcinoma arises from dysplastic tissue of Barrett's esophagus, a complication of gastroesophageal reflux disease (GERD), and is the fastest increasing cancer in the United States with a 600% increase over the past 25 years. Esophageal adenocarcinoma, which is linked to Barrett's esophagus, has one of the highest mortality rates in oncology, as more than 80% of patients diagnosed with esophageal adenocarcinoma have already progressed to advanced-stage cancer at the time of diagnosis. Stella Diagnostics’ mass spectroscopy-based proteomic assay, STLA101, offers physicians insight into the molecular properties of their patients’ tissue to determine if the disease is stable, progressing or turning cancerous.

Stella Diagnostics’ assay works in concert with current routine screening sequences to inform physicians of the biomarkers playing a role in the pathogenesis of GERD, Barrett's esophagus, and esophageal cancer. The company is currently undergoing optimization on its BEsmart™ proteomic panel (STLA101) in partnership with mProbe, Inc., and has multiple collaborative research agreements with leading institutions around the U.S., including the Mayo Clinic and Kansas University Medical Center, to assess assay performance of the BEsmart™ Test.

BioTech Breakthrough is a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe. The mission of the annual BioTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the top technology companies, solutions, and products in the life sciences and biotechnology industry today.

About Stella Diagnostics

Stella Diagnostics, Inc. is a molecular diagnostics-based organization focused on improving patient management strategies for over 60 million people living with severe esophageal disease. Stella Diagnostics’ clinical assay will offer physicians insight into the molecular properties of their patients' tissue to determine if the disease is stable, progressing or turning cancerous. Using targeted mass spectrometry proteomics, we believe that informing physicians of the expression patterns playing a role in the pathogenesis of GERD, Barrett's esophagus and esophageal cancer early in the treatment plan may extend or save lives. For more information, please visit www.stelladx.com.

Forward Looking Statements

Certain statements made in this press release are "forward looking statements" that are based on Stella Diagnostics' beliefs, assumptions, current expectations, estimates and projections. Forward looking statements involve known and unknown risks and uncertainties that may cause forecasted results to differ from actual results. Such risks include, but are not limited to market conditions, competitive factors, the ability to complete the proposed transaction and other such related risks. Stella Diagnostics can give no assurances that any projections related to revenues, profit margins or profits will be realized. Statements that are not historical fact, including without limitation statements which are preceded by, followed by or include the words "believes," "anticipates," "plans," "expects," "estimates," "may," "should," "intends," or similar expressions are forward looking statements. While Stella Diagnostics believes these assumptions, expectations, estimates, and projections are reasonable, such statements are subject to risks and uncertainties, certain of which are beyond our control and therefore, actual results may differ materially. Stella Diagnostics believes that many of the risks detailed here are part of doing business in the industry in which we would operate and compete. Forward looking statements only speak as of the date hereof and we do not undertake and expressly disclaim any obligation to update or release any revisions to any forward-looking statement whether as a result of new information, future events or otherwise except as required by law. While we believe the information used in this press release to be reliable, its accuracy has not been independently verified and cannot be guaranteed. Stella Diagnostics can give no assurances that any projections related to revenues, profit margins or profits will be realized.

Investors and Media Contact:

David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: info@stelladx.com
Skype: kugsusa
LinkedIn: https://www.linkedin.com/in/davidkugelman

$EAWD Energy and Water Development Corp. Establishes Common Stock Equity Agreement to Support its Growth
Press Release | 02/16/2022
Proceeds to Be Used to Increase Market Penetration and Sales

ST. PETERSBURG, FL / ACCESSWIRE / February 16, 2022 / Energy and Water Development Corp. (OTC PINK:EAWD) (the "Company"), an engineering company focused on delivering innovative and sustainable solutions of water and energy, today announced that it entered into a common stock purchase agreement and registration rights agreement (together, the "Agreements") with an institutional investor for up to $5 million worth of shares issuable over a 24-month period time, based upon the current market price of the stock at the time. Separately, upon entering into the Agreements, the investor made an initial fixed price equity investment of $300,000 at the then market price, no discount, which is subject to Rule 144 and a 6-month holding period.

Ralph Hofmeier, Chief Executive Officer of Energy and Water Development Corp., stated, "I want to reiterate that this investment is a step up for us, as the upfront capital of $300,000 is substantial for us to continue to grow our sales and it is in common stock equity at a fixed price. Of note, the common stock equity agreement will provide us additional growth capital to increase our sales and is at our control and discretion in regards to the amounts and timing. We believe this financing is not dilutive to current shareholders and enhances our value by increasing our cash and shareholder equity positions over time. It better positions us toward our capital markets goal for 2022-23 of an uplist to a major U.S. national exchange."

Hofmeier, continued, "We are extremely happy to partner with this institutional investor in regards to a common stock equity agreement. This is a major milestone for our Company, as we look to accelerate the number of active projects and revenue in 2022. Energy Development & Water is an emerging growth company going after a multi-billion-dollar market opportunity.If we had more capital to deploy, we could be growing much faster and this is a market that is rewarding growth. We are confident that the existing capital structure will support our operational cash flow requirements while providing the flexibility to achieve our growth targets. Plenty of high-profile public companies utilize similar equity agreements including American Battery Technology, Roku, Ballard Power among others, which have all seen their stocks perform very well post announcements. Of extreme importance to us was the faith and enthusiasm of the investor to provide a $300,000 upfront investment at a fixed equity price and our control over the timing and amounts of future equity capital which allows us to take advantage of sudden increases in our stock price."

Following the initial investment, and subject to the conditions of the Agreements, including that a registration statement is filed and declared effective with the Securities and Exchange Commission the Company has the right, in its sole discretion, to sell up to an additional $5 million worth of shares over a 24-month period. The Company will control the timing and amount of any sales to the investor and the investor is obligated to make purchases in accordance with the Agreements.

There are no upper limits to the price per share the investor may pay to purchase common stock and the purchase price of the shares will be based on the then prevailing market prices of the Company's shares at the time of each sale. No warrants, derivatives, financial or business covenants are associated with the Agreements.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering, nor will there be any sale of these securities in any jurisdiction in which such offer solicitation or sale are unlawful prior to registration or qualification under securities laws of any such jurisdiction.

Energy and Water Development Corp.

Energy and Water Development Corp. (OTC PINK:EAWD) is an engineering solutions company focused on delivering innovative and sustainable solutions of water and energy. EAWD builds its systems out of proven technologies, using their technical know-how to customize solutions to their clients' needs. The Company offers design, construction, maintenance and specialty consulting services to private companies, government entities and non-government organizations (NGOs).

For additional information, please visit: https://energy-water.com

Forward-Looking Statements:

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to Energy and Water Development Corp., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Corporate:
investor.relations@energy-water.com

Investor Relations Contact:
Brian Loper
ClearThink
bloper@clearthink.capital
p347-413-4234

$EAWD Energy and Water Development Corp. Establishes Common Stock Equity Agreement to Support its Growth
Press Release | 02/16/2022
Proceeds to Be Used to Increase Market Penetration and Sales

ST. PETERSBURG, FL / ACCESSWIRE / February 16, 2022 / Energy and Water Development Corp. (OTC PINK:EAWD) (the "Company"), an engineering company focused on delivering innovative and sustainable solutions of water and energy, today announced that it entered into a common stock purchase agreement and registration rights agreement (together, the "Agreements") with an institutional investor for up to $5 million worth of shares issuable over a 24-month period time, based upon the current market price of the stock at the time. Separately, upon entering into the Agreements, the investor made an initial fixed price equity investment of $300,000 at the then market price, no discount, which is subject to Rule 144 and a 6-month holding period.

Ralph Hofmeier, Chief Executive Officer of Energy and Water Development Corp., stated, "I want to reiterate that this investment is a step up for us, as the upfront capital of $300,000 is substantial for us to continue to grow our sales and it is in common stock equity at a fixed price. Of note, the common stock equity agreement will provide us additional growth capital to increase our sales and is at our control and discretion in regards to the amounts and timing. We believe this financing is not dilutive to current shareholders and enhances our value by increasing our cash and shareholder equity positions over time. It better positions us toward our capital markets goal for 2022-23 of an uplist to a major U.S. national exchange."

Hofmeier, continued, "We are extremely happy to partner with this institutional investor in regards to a common stock equity agreement. This is a major milestone for our Company, as we look to accelerate the number of active projects and revenue in 2022. Energy Development & Water is an emerging growth company going after a multi-billion-dollar market opportunity.If we had more capital to deploy, we could be growing much faster and this is a market that is rewarding growth. We are confident that the existing capital structure will support our operational cash flow requirements while providing the flexibility to achieve our growth targets. Plenty of high-profile public companies utilize similar equity agreements including American Battery Technology, Roku, Ballard Power among others, which have all seen their stocks perform very well post announcements. Of extreme importance to us was the faith and enthusiasm of the investor to provide a $300,000 upfront investment at a fixed equity price and our control over the timing and amounts of future equity capital which allows us to take advantage of sudden increases in our stock price."

Following the initial investment, and subject to the conditions of the Agreements, including that a registration statement is filed and declared effective with the Securities and Exchange Commission the Company has the right, in its sole discretion, to sell up to an additional $5 million worth of shares over a 24-month period. The Company will control the timing and amount of any sales to the investor and the investor is obligated to make purchases in accordance with the Agreements.

There are no upper limits to the price per share the investor may pay to purchase common stock and the purchase price of the shares will be based on the then prevailing market prices of the Company's shares at the time of each sale. No warrants, derivatives, financial or business covenants are associated with the Agreements.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering, nor will there be any sale of these securities in any jurisdiction in which such offer solicitation or sale are unlawful prior to registration or qualification under securities laws of any such jurisdiction.

Energy and Water Development Corp.

Energy and Water Development Corp. (OTC PINK:EAWD) is an engineering solutions company focused on delivering innovative and sustainable solutions of water and energy. EAWD builds its systems out of proven technologies, using their technical know-how to customize solutions to their clients' needs. The Company offers design, construction, maintenance and specialty consulting services to private companies, government entities and non-government organizations (NGOs).

For additional information, please visit: https://energy-water.com

Forward-Looking Statements:

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target," "intend" and "expect" and similar expressions, as they relate to Energy and Water Development Corp., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Corporate:
investor.relations@energy-water.com

Investor Relations Contact:
Brian Loper
ClearThink
bloper@clearthink.capital
p347-413-4234

$NMXS Net Medical's Upper Respiratory Test Identifies COVID, Flu and the Common Cold; More States To Be Added
Press Release | 02/16/2022
Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and growing.

ALBUQUERQUE, NM / ACCESSWIRE / February 16, 2022 / Net Medical Xpress Solutions (OTC PINK:NMXS) said today it is providing Gold Standard PCR testing for Covid, ordinary flu, colds and related other upper respiratory infections to the people of New Mexico.


With mobile vans currently operating in Albuquerque and Taos, Net Medical now offers bioMerieux's proprietary PCR testing module that make it quick, inexpensive and easy for those affected to quickly get a definitive idea of the illness they might be facing. Results of the tests are quickly known and instantly made available to appropriate authorities facilitating travel, going to work, job interviews, etc.

The initial program has been so successful that Net Medical is now planning similar programs for other states.

Net Medical CEO Dick Govatski said, "The roll out of our respiratory testing vans has been an enormous success. We have experienced high volumes of those seeking definitive information about their health status.

"Because of the Covid pandemic, people want and need information about the status of their health. Our mobile testing sites are the answer. At the end of December, the CDC expressed concerns about tests that couldn't distinguish between Covid, traditional influenza or a common cold. We selected bioMerieux's proprietary PCR testing module because it is the only test that can detect 22 separate viral pathogens and has been cleared by the FDA."

Now it is easy for those affected to quickly and conveniently obtain definitive knowledge of what they are facing. The process is easy, fast and official. And the tests are free to the public.

"bioMerieux,'s respiratory panel covers multiple targets in a single test accurately detecting and identifying pathogens most commonly associated with upper respiratory infections. If you are planning to travel and you suddenly come down with a cold, it's important to know whether it's just a common cold of something more serious," Govatski said.

Net Medical is one of the few companies providing mobile labs along with the software, trained personnel and licensed physicians that enable quick and accurate reporting to federal and state medical authorities.

About bioMerieux -- bioMerieux has been a major global player in the field of diagnostics for infectious diseases for more than 55 years. Their website is https://www.biomerieux.com and www.biofiredx.com.

For more information, call 505-255-1999. X 320. Visit www.netmedical.com. Email ir@netmedical.com

About Net Medical - publicly traded (OTC PINK:NMXS) since 1999.

Net Medical Xpress has two operating units. Net Medical Xpress provides telemedicine solutions for hospitals, nursing homes, specialty hospitals and other medical facilities. The company specializes in teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare and telenephrology. We maintain a 24/7/365 call center, software developers, and telemedicine platforms. In additional, Net Medical Labs is a moderate complex CLIA certified lab that specializes in virus testing and diagnostics. The company uses bioMerieux's proprietary PCR testing module because it is the only test that can detect 22 separate viral pathogens and has been approved by the FDA. The company's mobile fleet of vans is utilized to provide statewide COVID and FLU testing for schools, companies, homeless shelters, and nursing homes. The lab also serves as a reference lab for physician offices, and other facilities that lack services for complex virus diagnostics.

SOURCE: Net Medical Xpress Solutions, Inc.

$NMXS Net Medical's Upper Respiratory Test Identifies COVID, Flu and the Common Cold; More States To Be Added
Press Release | 02/16/2022
Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and growing.

ALBUQUERQUE, NM / ACCESSWIRE / February 16, 2022 / Net Medical Xpress Solutions (OTC PINK:NMXS) said today it is providing Gold Standard PCR testing for Covid, ordinary flu, colds and related other upper respiratory infections to the people of New Mexico.


With mobile vans currently operating in Albuquerque and Taos, Net Medical now offers bioMerieux's proprietary PCR testing module that make it quick, inexpensive and easy for those affected to quickly get a definitive idea of the illness they might be facing. Results of the tests are quickly known and instantly made available to appropriate authorities facilitating travel, going to work, job interviews, etc.

The initial program has been so successful that Net Medical is now planning similar programs for other states.

Net Medical CEO Dick Govatski said, "The roll out of our respiratory testing vans has been an enormous success. We have experienced high volumes of those seeking definitive information about their health status.

"Because of the Covid pandemic, people want and need information about the status of their health. Our mobile testing sites are the answer. At the end of December, the CDC expressed concerns about tests that couldn't distinguish between Covid, traditional influenza or a common cold. We selected bioMerieux's proprietary PCR testing module because it is the only test that can detect 22 separate viral pathogens and has been cleared by the FDA."

Now it is easy for those affected to quickly and conveniently obtain definitive knowledge of what they are facing. The process is easy, fast and official. And the tests are free to the public.

"bioMerieux,'s respiratory panel covers multiple targets in a single test accurately detecting and identifying pathogens most commonly associated with upper respiratory infections. If you are planning to travel and you suddenly come down with a cold, it's important to know whether it's just a common cold of something more serious," Govatski said.

Net Medical is one of the few companies providing mobile labs along with the software, trained personnel and licensed physicians that enable quick and accurate reporting to federal and state medical authorities.

About bioMerieux -- bioMerieux has been a major global player in the field of diagnostics for infectious diseases for more than 55 years. Their website is https://www.biomerieux.com and www.biofiredx.com.

For more information, call 505-255-1999. X 320. Visit www.netmedical.com. Email ir@netmedical.com

About Net Medical - publicly traded (OTC PINK:NMXS) since 1999.

Net Medical Xpress has two operating units. Net Medical Xpress provides telemedicine solutions for hospitals, nursing homes, specialty hospitals and other medical facilities. The company specializes in teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare and telenephrology. We maintain a 24/7/365 call center, software developers, and telemedicine platforms. In additional, Net Medical Labs is a moderate complex CLIA certified lab that specializes in virus testing and diagnostics. The company uses bioMerieux's proprietary PCR testing module because it is the only test that can detect 22 separate viral pathogens and has been approved by the FDA. The company's mobile fleet of vans is utilized to provide statewide COVID and FLU testing for schools, companies, homeless shelters, and nursing homes. The lab also serves as a reference lab for physician offices, and other facilities that lack services for complex virus diagnostics.

SOURCE: Net Medical Xpress Solutions, Inc.

$VTXB Vortex Brands Continues to Expand with Purchase Of Additional S19j
Press Release | 02/16/2022
Vortex Brands Continues to Expand with Purchase Of Additional S19j
PR Newswire

DENVER, Feb. 16, 2022

DENVER, Feb. 16, 2022 /PRNewswire/ -- Vortex Brands Co. (OTC: VTXB) announces it has acquired 5 additional S19j Pro (100th) for its Bitcoin Mining operations increasing its current order of S19j Pro to 19. The Company is expecting its S19j Pros to begin coming on-line in the this month. This represents the 3rd purchase of new mining equipment for the company this year.

We launched our bitcoin mining in September 2022. Since that time, we have expanded our bitcoin mining operations and began executing on our dividend policy of 15% of the net proceeds generated from the bitcoin mining operations.

As promised, we will provide as much transparency as possible to our shareholders regarding our Bitcoin Mining operations. As part of this, we will provide updates from the mining results to provide our shareholders with up-to-date information instead of making them wait until quarterly filings are made. Shareholder are encouraged to follow progress by viewing our corporate Bitcoin wallet address as provided below, to track our daily progress.

The wallet can be viewed by shareholders at:
https://www.blockchain.com/btc/address/38xnQP3mbWoDQTqLZy3GFMZyd2bwigvwCp

About Vortex Brands Co.: The Company operates as Technology Holdings Company that focuses on cryptocurrency sector, particularly Bitcoin Mining. Additional information is available by visiting company's website at www.vortexbrands.us or on twitter at https://twitter.com/Vortexbrands.

*Revenue related calculations. Please note that the Company believes that any revenue related calculations are accurate and based on factual information, there can be no assurance that the Company will be able to achieve all projections due to number of business-related factors, such as power pricing, mining equipment availability, bitcoin mining difficulty, bitcoin market pricing and other unforeseen issues in deploying its mining rigs. You can view update information on Bitcoin Mining by visiting https://minerstat.com/coin/BTC

Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating) to change or differ from future results, performance (financing and operating) or achievements, including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.



Cision View original content:https://www.prnewswire.com/news-releases/vortex-brands-continues-to-expand-with-purchase-of-additional-s19j-301483662.html

$VTXB Vortex Brands Continues to Expand with Purchase Of Additional S19j
Press Release | 02/16/2022
Vortex Brands Continues to Expand with Purchase Of Additional S19j
PR Newswire

DENVER, Feb. 16, 2022

DENVER, Feb. 16, 2022 /PRNewswire/ -- Vortex Brands Co. (OTC: VTXB) announces it has acquired 5 additional S19j Pro (100th) for its Bitcoin Mining operations increasing its current order of S19j Pro to 19. The Company is expecting its S19j Pros to begin coming on-line in the this month. This represents the 3rd purchase of new mining equipment for the company this year.

We launched our bitcoin mining in September 2022. Since that time, we have expanded our bitcoin mining operations and began executing on our dividend policy of 15% of the net proceeds generated from the bitcoin mining operations.

As promised, we will provide as much transparency as possible to our shareholders regarding our Bitcoin Mining operations. As part of this, we will provide updates from the mining results to provide our shareholders with up-to-date information instead of making them wait until quarterly filings are made. Shareholder are encouraged to follow progress by viewing our corporate Bitcoin wallet address as provided below, to track our daily progress.

The wallet can be viewed by shareholders at:
https://www.blockchain.com/btc/address/38xnQP3mbWoDQTqLZy3GFMZyd2bwigvwCp

About Vortex Brands Co.: The Company operates as Technology Holdings Company that focuses on cryptocurrency sector, particularly Bitcoin Mining. Additional information is available by visiting company's website at www.vortexbrands.us or on twitter at https://twitter.com/Vortexbrands.

*Revenue related calculations. Please note that the Company believes that any revenue related calculations are accurate and based on factual information, there can be no assurance that the Company will be able to achieve all projections due to number of business-related factors, such as power pricing, mining equipment availability, bitcoin mining difficulty, bitcoin market pricing and other unforeseen issues in deploying its mining rigs. You can view update information on Bitcoin Mining by visiting https://minerstat.com/coin/BTC

Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating) to change or differ from future results, performance (financing and operating) or achievements, including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.



Cision View original content:https://www.prnewswire.com/news-releases/vortex-brands-continues-to-expand-with-purchase-of-additional-s19j-301483662.html

$SGTB Suggestion Box, Inc. (OTC:SGTB) Submits for Corporation Name Provides Shareholder Updates
Press Release | 02/17/2022
Las Vegas, Nevada, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Suggestion Box (OTC Pink: SGTB) proudly announces it has filed for its new corporate name in the State of Texas.

Tony D’Antonio, Chief Executive Officer, states “We are excited to move forward with the new corporate name of Feel Better Labs, Inc. which directly reflects the direction and operations of the incoming merging company and its product line. In the coming weeks, the company plans to finalize the merger with ZapVir, Inc. and intends that the name of Feel Better Labs, Inc. becoming the name of the public corporation.” Mr. David Olund, Chairman, says, “Given that the company is focused to sales and distribution of over-the-counter, germ killing consumer health product lines, we are rebranding the our company and products to be in alignment with becoming a nationally and internationally recognized brand.”

Mr. D’Antonio adds, “We also want to update our shareholders that we are finalizing the terms and conditions for the upcoming merger of the operating company. In the past few weeks, we have also been working with our attorneys to complete the name and symbol change with FINRA. We want to let our shareholders know that no reverse split is planned for the foreseeable future and we expect to provide the details of the final transaction and announce a completed merger to our shareholders in the coming weeks.”

About SGTB/ZapVir, Inc.

ZapVir, Inc. is a company that manufactures and sells Over-The-Counter antiseptic consumer health products focused on Nasal/Sinus Care, Throat Care, Skin Care and Personal Environments with a focus on Homeopathic remedies.

To subscribe to company updates, please visit the Company's website at www.zapvirinc.com

Also note the company has updated its Twitter address to https://twitter.com/ZapvirInc.

About SinoFresh®

The SinoFresh® homeopathic antiseptics allow the body to get a head-start on fighting off infection. By stimulating the body’s natural defenses, homeopathic antiseptics promote removal of triggers of inflammation and/or infection such as bacteria, viruses, molds, and allergens. SinoFresh® Homeopathic Antiseptic Nasal Spray is non-habit forming, non-drying, and will not cause drowsiness. SinoFresh® is safe for use by children 12 year of age and older, diabetics, pregnant or lactating women, and hypertensive individuals. SinoFresh® KoolBlast Homeopathic Antiseptic Throat Spray is a daily use, antiseptic and soothing blend of ingredients for people with scratchy, irritated, raw, or sore throats. It is also an oral antiseptic blend that helps keep oral germs under control and can be used to freshen breath. It is non-habit forming, non-drying, and will not cause drowsiness. SinoFresh® Foaming Hand & Body Sanitizer is a skin sanitizing product applied as a foam to your hands or skin and rubbed in and allowed to dry. Our special formula of HI IQ water is the key ingredient that utilizes specially formulated water as the active ingredient.

Contact Information:

SGTB Shareholder/Investor inquiries can be directed to:

888-201-2003
Investors@zapvirinc.com

Contact Information:

SGTB Shareholder/Investor inquiries can be directed to:

888-201-2003
Investors@zapvirinc.com

Safe Harbor Statement: In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE: ZapVir, Inc.

$SGTB Suggestion Box, Inc. (OTC:SGTB) Submits for Corporation Name Provides Shareholder Updates
Press Release | 02/17/2022
Las Vegas, Nevada, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Suggestion Box (OTC Pink: SGTB) proudly announces it has filed for its new corporate name in the State of Texas.

Tony D’Antonio, Chief Executive Officer, states “We are excited to move forward with the new corporate name of Feel Better Labs, Inc. which directly reflects the direction and operations of the incoming merging company and its product line. In the coming weeks, the company plans to finalize the merger with ZapVir, Inc. and intends that the name of Feel Better Labs, Inc. becoming the name of the public corporation.” Mr. David Olund, Chairman, says, “Given that the company is focused to sales and distribution of over-the-counter, germ killing consumer health product lines, we are rebranding the our company and products to be in alignment with becoming a nationally and internationally recognized brand.”

Mr. D’Antonio adds, “We also want to update our shareholders that we are finalizing the terms and conditions for the upcoming merger of the operating company. In the past few weeks, we have also been working with our attorneys to complete the name and symbol change with FINRA. We want to let our shareholders know that no reverse split is planned for the foreseeable future and we expect to provide the details of the final transaction and announce a completed merger to our shareholders in the coming weeks.”

About SGTB/ZapVir, Inc.

ZapVir, Inc. is a company that manufactures and sells Over-The-Counter antiseptic consumer health products focused on Nasal/Sinus Care, Throat Care, Skin Care and Personal Environments with a focus on Homeopathic remedies.

To subscribe to company updates, please visit the Company's website at www.zapvirinc.com

Also note the company has updated its Twitter address to https://twitter.com/ZapvirInc.

About SinoFresh®

The SinoFresh® homeopathic antiseptics allow the body to get a head-start on fighting off infection. By stimulating the body’s natural defenses, homeopathic antiseptics promote removal of triggers of inflammation and/or infection such as bacteria, viruses, molds, and allergens. SinoFresh® Homeopathic Antiseptic Nasal Spray is non-habit forming, non-drying, and will not cause drowsiness. SinoFresh® is safe for use by children 12 year of age and older, diabetics, pregnant or lactating women, and hypertensive individuals. SinoFresh® KoolBlast Homeopathic Antiseptic Throat Spray is a daily use, antiseptic and soothing blend of ingredients for people with scratchy, irritated, raw, or sore throats. It is also an oral antiseptic blend that helps keep oral germs under control and can be used to freshen breath. It is non-habit forming, non-drying, and will not cause drowsiness. SinoFresh® Foaming Hand & Body Sanitizer is a skin sanitizing product applied as a foam to your hands or skin and rubbed in and allowed to dry. Our special formula of HI IQ water is the key ingredient that utilizes specially formulated water as the active ingredient.

Contact Information:

SGTB Shareholder/Investor inquiries can be directed to:

888-201-2003
Investors@zapvirinc.com

Contact Information:

SGTB Shareholder/Investor inquiries can be directed to:

888-201-2003
Investors@zapvirinc.com

Safe Harbor Statement: In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE: ZapVir, Inc.

$GTEH GenTech’s Fizzique™ Retail Footprint Starts to Grow with Purchase Orders from Nationwide Retailers
Press Release | 02/15/2022
Wheat Ridge, COLORADO, Feb. 15, 2022 (GLOBE NEWSWIRE) -- GenTech Holdings, Inc. (OTC Pink: GTEH) (“GenTech” or the “Company”), (a/k/a Supplement Group (USA) Inc.,) (www.gentechholdings.com) an emerging leader in the Functional Food (www.sinfit.com) and Nutritional Supplement (www.americanmetabolix.com) marketplaces, is proud to announce that its retail footprint for its brand Fizzique™ (www.drinkfizzique.com) has now embarked on an exciting new era of growth with orders from several national retailers and regional health store power houses.

With its first orders coming from UNFI® for various retail chains that will soon be unveiled, these exciting new orders are being dispatched nationwide from York, PA through Greenwood, IN to Riverside CA. As well, Kingdom Nutrition Hutton Texas (https://kingdomnutrition.com) are to receive their first inventory of Fizzique™ within 10 days with Max Muscle in Modesto, CA (https://stores.maxmuscle.com/ca-modesto-575) receiving their inventory last week.

Online retailer Muscle and Strength (www.muscleandstrength.com) are also in the process of adding all four of the Fizzique flavors to their website after having placed a significant order for the product and customers are expected to be able to place orders online by the end of this week.

The latest distributor to sign up for selling Fizzique and placing orders is “Park Avenue Fitness Distribution”, an independent distributor with an impressive array of well-known retailers in their established client stable. Family owned and operated since 2004, they service over +1000 retail gyms and health stores in the Mid-West and expect their first order for Fizzique to be placed in the Des Moines based gym chain “Genesis Health Clubs”, with over 70 locations throughout the region. (www.genesishealthclubs.com)

CEO of the company’s operating subsidiaries, Leonard K. Armenta Jr. recently appeared on MoneyTV (www.moneytv.net) to walk shareholders through this exciting new growth era, as well as to talk over the expansion plans for Storm™, another of the company’s brands, and how the market penetration is going for both of these young brands of the company: (https://vimeo.com/668290510)

Fizzique™ recently announced that it has signed Megan Olivi (http://meganolivi.com) as brand ambassador. Mrs. Olivi serves as a host and lead reporter for the UFC™ on ESPN™ as well as commenting on NFL™ for Fox™. During the fight broadcasts, Megan can be seen live reporting through the night, conducting interviews, and hosting from the desk. She also serves as a sideline and feature reporter during football season for NFL on Fox. Mrs. Olivi gets 1.25 million views on the UFC prelim fight and almost 2 million on the UFC pay per views per fight. As well as over 1m followers on various social media platforms and achieves exceptional engagement across all channels which are all essential metrics when choosing a Brand Ambassador.

About GenTech Holdings, Inc.
GenTech Holdings, Inc. (a/k/a Supplement Group (USA) Inc., www.supplementgrp.com) is a publicly traded company under the symbol GTEH. The Company owns and operates leading functional foods brand, SINFIT Nutrition, which offers a range of high-end Functional Foods as well as American Metabolix, Inc. which provides a diverse range of Nutritional Supplements through its brands American Metabolix, Storm Lifestyles and Core Natural Sciences.

www.sinfit.com www.americanmetabolix.com www.stormlifestyles.com www.nxtbar.com www.naturesoothie.com www.swftstims.com www.yourganics.com www.mpbsnacks.com www.drinkfizzique.com

Forward-Looking Statements
This press release may contain forward-looking statements, including information about management's view of GenTech, Inc.'s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of GenTech, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on GenTech's future results. The forward-looking statements included in this press release are made only as of the date hereof. GenTech cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, GenTech undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by GenTech.

Corporate Contact:
invest@gentech.group
www.gentechholdings.com

Public Relations:
EDM Media, LLC
https://edm.media

Attachment

$MJNA Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa and Japan Divisions in January 2022
Press Release | 02/15/2022
SAN DIEGO, CA, Feb. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® achieved its largest revenue month in the company’s history in its Japan and South Africa divisions in January 2022.

According to Business Insider Africa, Africa’s cannabis industry is projected to grow beyond a $7 billion valuation by 2023. Reach and Markets highlights that the Asia-Pacific market is also expected to grow exponentially with a CAGR of 28.6% from 2020 to 2027.

“Being able to achieve four best revenue months in a row in the Japan market has been both a great way to end 2021 and an inspiring way to start 2022,” said Medical Marijuana, Inc. CEO Blake Schroeder. “Now that we’ve reached this milestone in South Africa as well, we anticipate that both regions will be major market areas for us this year and beyond.”

To learn more about Kannaway®, please visit the Company online at https://www.kannaway.com/.

About Kannaway®
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.

Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

CONTACT:

Public Relations Contact:
Kathryn Brown
Account Director
CMW Media
P. 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
P. (858) 283-4016
Investors@medicalmarijuanainc.com